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Abbreviations and symbols
(v/v) volume to volume ratio
AcOH glacial acetic acid
CD cyclodextrin
CF cyclofructane
Crown 1-3 (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid-based chiral stationary phase
CSP chiral stationary phase
Et ethyl-
EtOH ethanol
H2O Milli-Q water
H2SO4 sulfuric acid
H3PO4 phosphoric acid
HClO4 perchloric acid
HCOOH methanoic acid
HILIC hydrophilic interaction chromatography
HPLC high-performance liquid chromatography
IPA 2-propanol
Me methyl-
MeOH methanol
MIP molecular imprinted polymer
MIT molecular imprinted technology
NaOH sodium hydroxide
NP normal-phase
Ph phenyl-
PI polar-ionic
PO polar-organic
Pr propyl-
PrOH 1-propanol
R ristocetin A-containing ChirobioticTM R column
RP reversed-phase
T teicoplanin-containing ChirobioticTM T column
T2 teicoplanin-containing ChirobioticTM T2 column
TAG teicoplanin aglycone-containing ChirobioticTM TAG column
TEA triethylamine
TEAA triethylammonium acetate
TFA trifluoracetic acid
V vancomycin-containing ChirobioticTM V column
VAG vancomycin aglycone-containing ChirobioticTM VAG column
k’ retention factor; defined as (tR-t0)/t0; tR, retention time; t0, column dead-time
 separation factor; defined as k’2/k’1; 1: first- and 2: second-eluting peakRS resolution; defined as 2(tR2-tR1)/(w1+w2); w, peak width measured on the
baseline
i1. INTRODUCTION AND AIMS
Chromatography has been defined as follows:
Chromatography is a separation process that is achieved by
distributing the components of a mixture between two phases:
a mobile phase and a stationary phase.
1.1. The history of liquid chromatography
The process of liquid chromatography was discovered in the 1890s by the Russian
botanist Tswett, who used it to separate and isolate various plant pigments. This was in fact
liquid-solid chromatography, which was the first type of chromatography [1]. The coloured
bands he produced on the adsorbent bed evoked the term chromatography for this type of
separation.
In 1913, Tswett’s experiment was repeated by Willstatter and Stoll, but they used an
aggressive adsorbent, and consequently the chlorophylls were decomposed [2].
Martin and Synge achieved a variant of liquid-liquid chromatography in the late
1930s and early 1940s. Some acetyl amino acids were separated on silica gel and in 1941
their work was published [3]. In that publication, they offered a suitable gas instead of the
liquid mobile phase, to accelerate the transfer between the mobile and stationary phases,
when the separation may be more effective. With this suggestion, the basis of gas
chromatography was created. Also in that paper, Martin and Synge recommended the
application of high pressures and small particles in liquid chromatography in order to reach
a better separation. This was the beginning of the development of high-performance liquid
chromatography (HPLC).
Nowadays, HPLC (like other chromatographic techniques) is an extremely versatile
technique with which to separate chemical materials (or enantiomers in chiral chemistry)
and also to purify medical agents, for example, from impurities.
1.2. The biological importance of -amino acids
-Amino acids occur in greater diversity than -amino acids, and have therefore
received increased research attention. Because of their unique biological, neurological and
pharmaceutical activities, unnatural amino acids are utilized as building blocks, molecular
scaffolds, conformational constraints, or pharmacologically active products [4,5]. -Amino
acids are key components of numerous bioactive molecules, such as peptides, alkaloids or
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-lactam antibiotics. They are used as precursors for antibiotics [6] and building blocks in
cryptophycins [7,8]. They are known to be receptor antagonists, enzyme inhibitors and also
components of naturally occurring compounds, e.g. taxol, one of the most active
antitumour agents, which contains phenylisoserine as its side-chain. They exhibit
hypoglycaemic and antiketogenic activities in rats [9].
They represent a nearly infinite array of diverse structural elements for the
development of new leads in peptidic and non-peptidic compounds, and -amino acids are
therefore also target compounds in the preparation of peptidomimetics. Novel short-chain
peptide ligand mimetics with both enhanced biological activity and proteolytic resistance
are drug candidates in today’s R&D pipelines of pharmaceutical companies. Optimized
and fine-tuned analogues of peptidic substrates, effectors or inhibitors are also excellent
analytical tools for the investigation of signal transduction pathways or gene regulation
[10-12].
In the past few years, interest in -peptides and -amino acid-containing oligomers
has increased in medical chemistry, because they display marked biological activity and
extreme biological stability [13]. An important aspect of biologically active peptides is
their ability to fold into compact helices and turn and pleated sheet conformations in
solution [14-17]. An understanding of the biologically active conformations of peptide
hormones is an important goal in modern biology. A cyclic -tetrapeptide was recently
synthetized with biological activity similar to that of somatostatin, an important
endogenous neurotransmitter and inhibitor of hormone secretion [18]. Systematic
replacement of an -amino acid by a -amino acid residue resulted in a hybrid
oligopeptide which binds to major histocompatibility complex proteins, while exhibiting
increased stability towards proteolysis [19-21].
1.3. The significance of chirality
If an organic molecule has an asymmetric centre and all four ligands of the carbon
atom are different from each other, then the molecule is asymmetrically chiral. A molecule
may also demonstrate axial, planar or inherent chirality. If these molecules are
superimposed on their mirror image and their physicochemical properties (melting point,
boiling point, density, solubility, etc.) are equal, they are called enantiomers. They can
rotate plane-polarized light (+/-) by equal amounts but in opposite directions, so they are
optically active molecules. A mixture composed of equal proportions of them is termed a
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racemic mixture or racemate and exhibits zero net rotation of plane-polarized light. If
molecules have two or more chiral centres, they do not have a mirror image and their
physical and chemical properties are different; they are termed diastereomers.
The interest in chirality and chiral effects increased in the past decade, due to
demands of biology, medicine, the pharmaceutical and food industries etc. [22]
In nature, most substances with biological and pharmacological effects are chiral,
e.g. amino acids, sugars, proteins and nucleic acids. In living systems, pharmaceutical
molecules react with asymmetric biological macromolecules in the course of physical and
chemical processes. This chiral environment can discriminate the enantiomers because the
biological properties of the enantiomers, such as protein transport and binding, their
stability in the environment and the kinetics of their metabolism, are different [23-25].
One of the enantiomers is often the more active stereoisomer for a given action
(eutomer), while the other, less active one (distomer) may either contribute side-effects,
display toxicity or act as an antagonist [26-28].
Naturally, there are some opposite cases, such as the example of two enantiomers
of Ibuprofen, whose spectra of activity and effect are equal, but the rates of uptake in the
organism may be different [29].
An unfortunate example of the latter situation was the case of Thalidomide [30]. In
the 1960s, racemic Thalidomide was given to pregnant women to inhibit nausea. While the
R isomer was a eutomer and was well applicable against nausea, the S isomer was
teratogenic, which caused defects in the embryos. It was later discovered, that the R
enantiomer racemizes in living systems to from the S isomer. Thalidomide was therefore
banned.
Consequently, discrimination of the enantiomers of medical agents is currently a
very important task. Either stereoselective synthesis or chromatographic enantioseparation
are applied. In a valid case, use of a racemate is allowed by the US Food and Drug
Administration (FDA), but a full scale of clinical and toxicological investigations of the
two enantiomers and the racemate is required [31,32]. However, the manufacture of
chirally pure compounds is generally cheaper for the pharmaceutical firms.
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1.4. Aims of this work
The primary aim of this work was to investigate the chiral separation of two types
of -amino acids on two different chiral stationary phases (CSPs), macrocyclic
glycopeptides and crown ether-based CSPs.
1. The enantioseparation of monoterpene-based -amino acids was investigated
on macrocyclic glycopeptide-based CSPs such as teicoplanin, ristocetin A and
vancomycin-based columns. The influence of the pH, the mobile phase composition, the
structures of the molecules, the sugar moieties of the selectors and temperature on the
chiral recognition was examined.
2. The enantioseparation of isoxazoline-fused 2-aminocyclopentanecarboxylic
acid analogues on macrocyclic antibiotic-based CSPs was studied, with the aim of
developing new chromatographic methods for their chiral separation. For this purpose, the
method was optimized by changing the chromatographic conditions (pH, mobile phase
composition, temperature, etc.).
3. For the enantioseparation of isoxazoline-fused 2-aminocyclopentanecarboxylic
acid analogues new types of crown ether-based selectors were used. With variation of the
chromatographic conditions, the goal was to determine the main interactions which
contribute to chiral recognition. The effects of the nature of the spacer used for the
immobilization of the selector was also studied.
4. The separation efficiencies of the two types of CSPs were compared on the
basis of the chromatographic data obtained for isoxazoline-fused 2-
aminocyclopentanecarboxylic acid analogues.
In all measurements, the chromatographic parameters (retention factors, selectivity
factors and resolutions) were determined; in the case of the temperature dependence, the
thermodynamic parameters were collected.
12. LITERATURE REVIEW
The physical and chemical properties of enantiomers are equal, and their
discrimination in the past was therefore too difficult. For the discrimination of
enantiomers, a chiral environment is required. Chiral separation is achieved with two
methods in chromatography.
The first is indirect separation, which is based on the formation of diastereomeric
derivatives through use of a chiral derivatizing agent. The diastereomers formed can be
separated on achiral stationary phases because their physico-chemical properties are
different.
The easiest way to achieve enantioseparation is direct separation, which involves
two methods: either the addition of a chiral mobile phase additive and separation of the
enantiomers on an achiral stationary phase or the more elegant and convenient application
of CSPs, where the chiral selector is adsorbed or chemically bonded to a silica support.
In this study, the direct method was used with the application of CSPs.
2.1. Direct separation with CSPs
The three-point contact model is the most reliable model which has sufficient
requirements to satisfy the chiral recognition (Fig. 1). It was suggested by Dalgliesh [33],
who discussed that three interactions have to predominate between the analyte and the
CSP. Pirkle and Pochapsky complemented this theory in that one of them has to be
stereoselective [34]. This model can still be used also today for most of the chiral
separation principles.
Figure 1. Explanation of the three-point model
2The preparation of chiral columns was a significant milestone in the 1980s. Since
that period, a large number of various types of CSPs have been created, which are grouped
according to the type of their selectors as follows: protein-based, Pirkle- or brush-type,
polymer-based, macrocyclic glycopeptide-based, cavity-type, ligand-exchange and
molecular imprinted CSPs.
2.1.1. Protein-based CSPs
In these stationary phases, natural proteins are bonded to a silica support. Bovine
serum albumin was initially applied as CSP for the enantioseparation of -amino acids by
Stewart et al. in 1973 [35]. Protein-based CSPs have a large number of chiral centres and
interact strongly with small compounds through the dipole-dipole, H-bonding and
hydrophobic interactions. The ionic strength and naturally the pH, the concentration and
nature of the organic modifier are known to influence the retention and resolution.
There are various protein groups in protein-based CSPs, such as albumins,
glycoproteins and enzymes. In the past few decades, there have been many publications
involving all types of protein-based CSPs [36].
2.1.2. Donor-acceptor (Pirkle-type or brush-type) CSPs
These CSPs contain neutral synthetic chiral low molecular mass selectors. William
H. Pirkle was the pioneer in the development of brush-type CSPs at the end of the 1970s
[37]. They are known to be able to activate donor-acceptor interactions (face-to-face or
face-to-edge - interactions and H-bonding) and dipole-dipole stacking in normal-phase
(NP) mode. An aromatic ring ensures the - interactions, and acidic and basic sites may
participate in intermolecular H-bonding interactions.
The -acidic and -basic-type Pirkle CSPs are well applicable for the separation of
alcohols, thiols, aromatic acids and their derivatives [38-41].
2.1.3. Polymer-based CSPs
The selectors of these CSPs are mainly cellulose or amylose. The cellulose-based
CSPs have a rigid, linear form, whereas amylose is helical. The interactions evolving
between the CSP and the analyte are H-bonding,- and dipole-dipole interactions. The
hydroxy groups on three carbon atoms of the saccharide ring can be modified by ester or
carbamate formation.
3The first racemate resolution was reported in 1951, by Kotake et al. [42]. They
resolved amino acids on polysaccharide-containing papers. Hesse and Hagel considered
microcrystalline cellulose triacetate as a polymeric selector in 1976 [43]. Okamoto et al.
attempted to enhance the enantioselectivity by coating a macroporous aminopropylsilica
gel with microcrystalline cellulose triacetate [44,45], and recognized that the
enantioselectivity can also increase if the hydroxy group, of the polysaccharide are
substituted. Coated polysaccharide CSPs had some disadvantages. Some solvents (i.e.
CH2Cl2, EtOAc, THF, dioxane, etc.) are incompatible with polysaccharides because they
are physically adsorbed on silica, so these solvents swell and/or dissolve the CSP in NP
mode. In 1987, Okamoto et al. covalently bonded a polysaccharide to aminopropylsilica
gel, which was the first immobilized polysaccharide-based CSP [46].
Modified polysaccharide-based CSPs were recently used to separate various types
of compounds, such as aromatic ring-containing racemic compounds [47], acidic drugs
[48], neutral pharmaceuticals [49], aminonaphthol analogues [50,51] and -lactam
derivatives [52].
2.1.4. Macrocyclic antibiotic-based CSPs
The study of antibiotics started in 1928, when the antibacterial action of penicillin
was discovered by A. Fleming. In 1953, the first macrocylic antibiotic, vancomycin, was
isolated by E. Kornfeld from a soil sample [53]. Vancomycin was also extracted from
Amycolatopsis orientalis [54]. This was the beginning of the discovery of more than 100
macrocyclic antibiotics. They exert biological activity to block the synthesis of the cell
wall of Gram(+) bacteria, but they have no effect on Gram(-) bacteria [55]. All of them
contain an aglycone unit (which forms a characteristic basket shape) and some sugar
moieties (except for the aglycone derivaties). Their molecular masses are in the range
1100-2100 Da.
These natural molecules were introduced as CSPs by Armstrong in 1994. This was
one of the most significant turning-points in chromatography. Armstrong recognized that
the several chiral centres and interactive points of macrocyclic antibiotics may be suitable
for interaction with a variety of different compounds [56].
These macromolecules were divided into four subclasses: ansamycins,
glycopeptides, polypeptides and aminoglycosides. As regards chromatography, the most
significant is the subclass of glycopeptides. Since 1994, hundreds of publications have
4appeared on the applications of glycopeptides: vancomycin, teicoplanin, ristocetin A,
avoparcin and their aglycone derivaties.
They contain numerous funcional groups, and therefore all kinds of interactions can
occuer, such as hydrophobic, -, dipole-dipole interactions, H-bonding, steric repulsion
and ionic or charge-to-charge interactions. Macrocyclic glycopeptides can be used in NP,
reversed-phase (RP), polar-organic (PO) and also polar-ionic (PI) mode.
Vancomycin (Fig. 2) was the first discovered glycopeptide. It is produced by
Streptomyces orientalis and Amycolatopsis orientalis. Vancomycin has 18 stereogenic
centres. It has two major parts. The aglycone basket is produced from three macrocyclic
parts containing five aromatic rings. It may be hypothesized that this portion is involved in
hydrophobic and - interactions.
Figure 2. The structure of vancomycin
Two of the aromatic rings have chlorine substituents, which have a -acidic
character and play a part in the formation of H-bonds. The nine hydroxy groups also
contribute the formation of H-bonds. There are also primary, and secondary amino and
carboxylic acid groups, which are responsible for ionic interactions. The aglycone portion
bears two sugar moieties, which may be responsible for steric effects [57].
Vancomycin aglycone is a derivative of vancomycin which lacks the disaccharide
units (Fig. 3). The lack of sugar units in some cases increases the enantioselectivity and
resolution [58].
5Figure 3. Vancomycin aglyone
Teicoplanin, produced by Actinoplanes teicomyceticus, is active against anaerobic
and aerobic Gram(+) bacteria [59]. It has an aglycone including four macrocyclic rings,
three sugar units and a hydrocarbon chain.
Figure 4. Stucture of teicoplanin A2-2
Natural teicoplanin consists of five derivatives, which differ only in the length of the
hydrocarbon chain. The main component of the teicoplanin complex is A2-2 (Fig. 4), with
23 stereogenic centres.
The macrocyclic rings contain seven aromatic rings, which able to form -
interactions with the analyte. Two of them are chloro-substituted and four of them contain
ionizable phenolic moeties. The aglycone basket consists of primary amino (pKa=9.2) and
carboxylic acid (pKa=2.5) groups. These two groups are the basis of ionic interactions,
which is characteristic of all of the CSPs. The three carbohydrate units are D-mannose, D-
6N-acetylglucosamine and D-N-acylglucosamine. The teicoplanin CSP is more surface-
active than other glycopeptides, because of the hydrophobicity of D-N-acylglucosamine,
caused by a hydrocarbon chain [60].
The first publications on the use of teicoplanin as a CSP appeared in 1995 [61]. In
the past few years, mostly teicoplanin-containing CSPs have been applied. They are able to
separate amino acids and their derivatives [62-64], peptides [65,66], mandelic and lactic
acid derivatives, non-steroidal anti-inflammatory drugs and N-blocked amino acids [67],
indole-based amino analogues [68], -blocker drugs [69], amino alcohols [70], etc.
Teicoplanin aglycone was synthetized from native teicoplanin (Fig. 5). It contains
the same heptapeptide backbone as teicoplanin, but it lacks the sugar units. Berthod et al.
recognized that the carbohydrate units are not necessary for the enantioresolution of
common -amino acids [71]. The cleft near the ureido terminal of the aglycone basket is
an important part of the receptor site for amino acid recognition. Amino acids have easier
access to this site on the aglycone, which produces much higher enantioselectivity and
resolution factors for these compounds relative to those achieved on a Chirobiotic T
column. However, Péter et al. have published mainly opposite results as concerns 3-
homoamino acids [64].
The phenolic and alcoholic hydroxy groups are protected by these carbohydrate
moieties blocking the formation of possible interactions. However, further interactions may
occure with the sample molecules through the alcoholic, ether and amide groups and the
nonyl chain of the sugar unit.
Figure 5. Structure of teicoplanin aglycone
7In the past decade numerous publications have reported that in many cases
teicoplanin aglycone is more efficient in enantiorecognition than the sugar-containing
teicoplanin [72-74].
The most polar macrocyclic glycopeptide is ristocetin A (Fig. 6) with 21 hydroxy
groups. It is produced by Proactinomyces fructiferi and Nocardia lurida [75]. It is an
important molecule in biochemistry. Ristocetin A selectively bonds to the D-Ala-D-Ala
sequence to influence cell wall synthesis [76]. It has 38 stereogenic centres, seven aromatic
rings and six sugar moieties. Two of the latter are D-mannose, one D-glucose, one L-
ristosamine, one L-rhamnose and one D-arabinose. Its aglycone contains four macrocyclic
rings, two amino groups and a carboxymethyl group, and it therefore interacts weakly with
cationic compounds.
Figure 6. Structure of ristocetin A
Ristocetin A acts well as a selector to separate the enantiomers of -amino acid and
their derivatives with free carboxylic acid moeties in capillary electrophoresis [77], N-
blocked amino acids [78], some synthetic amino acid analogues [79,80], peptides [80,81]
and hydroxyl group-containing -amino acids [74].
2.1.5. Cavity-type CSPs
Within cavity type-CSPs, three different groups are discriminated: cyclodextrin
(CD)-based, crown ether-containing and cyclofructan (CF)-based CSPs.
8CD-based CSPs were introduced by Armstrong and DeMond [82]. Three types of
CDs are well known in chromatography: -, - and -CDs with six, seven and eight
glucose moieties connected via an -1,4-linkage to the silica surface. The CDs inside the
cavity are hydrophobic due to the carbon backbone of the sugar units, while the upper and
lower ones are hydrophilic due to the hydroxy-groups. They can be used in NP, RP, PO or
PI mode.
CD is one of the most popular selectors in chiral separation. These CSPs have
proved useful for the resolution of coumarin derivatives [83], flavonones and flavonone
glycosides by nano-liquid chromatography [84], -lactams [85], chiral drugs [86] and
unnatural -amino acids [87].
Chiral crown ether-containing CSPs are another group of the cavity types. Crown
ethers were introduced by Pedersen in 1967 [88]. Cram and Sogah immobilized bis-(1,19-
binaphthyl)-22-crown-6 on silica gel by preparing the first crown ether-based CSP in 1979,
and the separations of various amino acids were investigated on it [89]. In 1987, 1,19-
binaphthyl-20-crown-6 was coated on octadecylsilica gel by Shinbo et al., who used this
material as CSP to separate D,L-amino acids [90,91]. The importance of crown ether-based
CSPs was increased when (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid was covalently
bonded to silica gel byMacchida [92].
Sawada et al. demonstrated the importance of the ether bond in the crown ether
ring with the FAB/MS technique. They replaced two ether bonds with two aromatic rings,
but this was not effective for chiral recognition [93].
After Machida [92], (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid was
covalently bonded to a modified aminopropylsilica support (Fig. 7) by Hyun et. al. [94].
With this crown ether, quinolone antibiotic enantiomers (primary and secondary amine
compounds) were resolved by Behr et al. [95].
O OO
OOOHOOC COOH
NHO
Si
HN
Si
ONH2
Si
NH2
Si
Figure 7. (+)-(18-Crown-6)-2,3,11,12-tetracarboxylic acid bound to silica gel (Crown 1)
9Later, the separations of racemic natural and unnatural -amino acids, -amino
esters and amides were reported by Hyun et al. [96]. The separation of amino acids was
successful, except in the case of proline, whereby it was concluded that the lack of a
primary amino group is impedes the formation of an ammonium ion-crown ether complex.
With this type of selector, one of the most essential interactions is the formation of
an ammonium ion-crown ether complex between the selector and the protonated primary
amine analyte (Fig. 8). Therefore, an acidic modifier should be added to the mobile phase
to protonate the primary amino group of the analyte. Besides these interactions, H-
bonding, dipole-dipole, hydrophobic, steric, etc. interactions similarly mean advantages.
Figure 8. Presumed structures of crown ether-ammonium ion complex
Lee et al. [97] reported that the high enantioselectivity of this type of CSP for -
amino acids was due to the H-bonding between one carboxylic acid in the CSP and a
carbonyl group oxygen in the amino acids.
In 2001, Hyun et al. modified the previously synthetized (+)-(18-crown-6)-
2,3,11,12-tetracarboxylic acid-containing CSP, but there was not a major change in chiral
recognition (Fig. 9) [98].
O OO
OOOHOOC COOH
NHO
Si
HN
Si
O
O O
Figure 9. The modified crown ether-containing selector (Crown 2)
The properties of the spacer were investigated by Hyun [99]. The (+)-(18-crown-6)-
2,3,11,12-tetracarboxylic acid was covalently bonded to the silica surface through an
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aminoundecyl group (Fig. 10). With this more apolar and more flexible selector, the
resolution increased in the case of less hydrophilic -amino acids, amines and amino
alcohols, but not in the case of -amino acids.
O OO
OOOHOOC COOH
NHO
Si
O
HN
Si
O
O
( )9 ( )9
Figure 10. The selector bonded to silica gel through an aminoundecyl chain (Crown 3)
Recently, many publications have appeared on the synthesis of 1,1’-binaphthyl
unit-containing and phenolic pseudo crown ether CSPs. With these, primary and secondary
amino compounds [100,101], enantiomers of fluoroquinolones including gemifloxacin (a
chemotherapeutic reagent for various infections) [102], some - and -amino acids [103-
105], di- and tripeptides [106], amino alcohols [107] and chiral drugs with free primary
amino groups [108] were resolved.
CF-based stationary phases are a new class of cavity-type CSPs. The CFs that
contain six, seven or eight -(2,1)-linked D-fructofuranose moieties are named CF6, CF7
and CF8. These sugar units contain four stereogenic centres and three hydroxyl groups,
and the central core has the same structure as in crown ethers. The first CF-based
stationary phases containing six D-fructofuranose units (CF6) were introduced by
Armstrong in 2009 [109]. Isopropyl carbamate-functionalized CF6 was able to separate
enantiomers of Betti base analogues [110], amino acids, amino acid amides, esters and
alcohols [111], and nucleic acids and nucleosides in HILIC mode by Qui et al. [112].
2.1.6. Ligand-exchange CSPs
Ligand-exchange chromatography was developed in the early 1970s by Davankov
and Rogozhin [113] and proved effective in the separation of amino acids. This was the
first enantioselective liquid chromatographic technique. Proline as selector was
immobilized onto a polystyrene surface, in combination with Cu(II) ions in the mobile
phase. The principle of ligand exchange is complex formation with a metal ion [Cu(II),
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Zn(II) or Ni(II)] between the analyte enantiomers to be resolved (containing electron-
donating functional groups such as hydroxy, amino, amido, thio, carboxyl, etc.) and the
chiral selector. Ligand-exchange CSPs have been employed to separate proline [114] and
cysteine derivatives [115] and also amino alcohols [116,117].
Hyun et al. [117,118] prepared new ligand-exchange CSPs based on (S)-N,N-
carboxymethyl undecyl leucinol monosodium salt and on (R)-N,N-carboxymethyl undecyl
phenylglycinol monosodium salt selectors. In the resolution of -amino acids, the latter
was always much better than the former in terms of both the separation factor () and
resolution (RS). The chromatographic behaviour depended on the Cu(II) concentration and
the content of the organic modifier.
2.1.7. Molecular imprinted CSPs
These stationary phases are of template type, which ensures high enantioselectivity.
Through molecular imprinting technology (MIT), the target molecule is copolymerized,
and the template is removed from the polymer by solute extraction, resulting in the exact
polymerized shape of the enantiomers. One of the pioneers of MIT was Mosbach [119-
121], and Wulff investigated antibodies [122]. Among others, (S)-ipuprofen- [123] and (S)-
propranolol-based [124] molecular imprinted polymers (MIP) were prepared by Haginaka
et al. Alanine and serine were separated on L-alanine- and L-serine-based MIPs [125].
Zhang et al. used one of the most important host molecules, CDs, to prepare MIPs [126].
Moreover, Silva et al. [127] applied supercritical CO2 technology to prepare MIPs to
separate tryptophan enantiomers.
In summary, a survey of the literature on the CSPs from the aspect of the
enantioseparation of protein and unusual amino acids reveals that only few of them can be
taken into consideration. The most popular and useful CSPs for the separation of amino
acids and their analogues are macrocyclic antibiotic- and crown ether-based phases.
However, the latter can be used only for amino acids containing primary amino groups.
Applications of CD-type CSPs generally need derivatization with a derivatizing agent
containing an aromatic group with -acidic or -basic character. The same holds for the
application of Pirkle-type and polysaccharide-based phases.
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2.2. Chemical and biological importance of monoterpene-based and
isoxazoline-fused 2-aminocyclopentanecarboxylic acids
Naturally occurring -amino acid cispentacin, icofungipen and oryzoxymycin are
bioactive compounds with antibacterial and antifungal properties. Icofungipen disturbs the
biosynthesis of protein in Candida albicans.
Enantiomerically pure -pinene, -pinene and 3-carene can be transformed into -
amino acid derivatives, which are excellent building blocks for the synthesis of
monoterpene-fused saturated 1,3-heterocycles. Apopinane-based -amino acids were used
as building blocks in the construction of stable H12 foldameric helices and in Ugi four-
centre three-component reactions.
Amino acids containing an isoxazoline moiety have revealed anti-influenza
activities and antifungal properties. Several isoxazole carboxylic acids, such as
conformationally constrained aspartate and glutamate analogues, have been reported as
enzyme inhibitors or agents possessing neuroprotective activities. Isoxazoline-fused amino
acids have served as important precursors for the synthesis of novel multisubstituted
cyclopentene derivatives with antiviral activities.
2.3. Thermodynamic principles of temperature dependence
Enthalpy, a measure of the total energy of a thermodynamic system, is defined as:
pVUH  (1)
where U = internal energy
p = pressure
V = volume
In classical thermodynamics, entropy is defined by the second law of
thermodynamics, which states that the entropy of an isolated system always increases or
remains constant. Thus, entropy is also a measure of the tendency of a process:
0dS (2)
Enthalpy (H) and entropy (S) can describe a state where both reactants and products
are in standard state, called standard reaction enthalpy / reaction entropy.
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The position of equilibrium depends on the temperature and pressure in the system.
In thermodynamics, Gibbs free energy (G) is a thermodynamic potential that measures the
useful or process-initiating work obtainable from a thermodynamic system at a constant
temperature and pressure. It is defined as:
TSHG  (4)
The standard Gibbs free energy of equilibrium formation is
rrr QRTGG ln (5)
where R = gas constant
T = absolute temperature
Qr = reaction quotient
At equilibrium, rG = 0 and Qr = K, and therefore the equation is modified:
KRTGr ln (6)
where: K = equilibrium constant
This Gibbs-Helmholz formula [Eq. (6)] is rearranged to ln K differentiated with respect to
T and substituted into Equation (4) to give a van’t Hoff type equation:
2
ln
RT
H
dT
Kd  (7)
A rearranged form of Eq. (7) is used to investigate the effects of temperature in
chromatography:
R
H
Td
Kd )/1(
ln (8)
If ln K is plotted vs. 1/T, we obtain the right-hand side as slope, and H° can be
determined. From Eq. (4), the standard Gibbs free energy is described as follows:
 STHG (9)
where H° = standard change of enthalpy
S° = standard change of entropy
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In chromatography, one of the most important data is the retention factor (k’),
which is a measure of the stochiometric mass distribution of the analyte between the
mobile and stationary phases. The relationship between k’ and K is:

Kk '
S
M
V
V where: ß is the phase ratio (10)
With the previous equation, Eq. (6) is modified as
'ln kRTG  (11)
The previous equation is rearranged to express k’, to give the equation used in
chromatography:
ln'ln  R
S
RT
Hk (12)
Eq. (12) shows that a plot of ln k’ vs. 1/T has a slope of –H°/R and an intercept of
S°/R + ln if H° is invariant with temperature (ln is the inverse of the phase ratio; if
ln is not known, the value of the intercept multiplied by R is dinoted S°* in
chromatography).
In chiral chromatography, the difference the changes of standard free energy of the
two enantiomers is used for determinations:
)(12  GGG (13)
A combine Eq. (6) and (13) gives
'
'ln)(
1
2
k
kRTG  (14)
As  = k2’/k1’:
R
S
RT
H )()(ln  (15)
From this, it can be determined whether the separation is an enthalpy-driven or an
entropy-driven process. In the first case, increasing temperature lowers the
enantioselectivity and enantioseparation. In an entropy-driven process, increasing
temperature increases the enantioselectivity.
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3. EXPERIMENTAL
3.1. Apparatus
Our measurements were carried out with three HPLC systems.
System I: An M-600 low-pressure gradient pump, equipped with an M-2996
photodiodearray detector and a Millenium32 3.2 Chromatography Manager data system (all
Waters Chromatography, Milford, MA, USA).
System II: A 1525 binary pump, a 2487 dual-channel absorbance detector, a 717
plus autosampler and Empower 2 data manager software (all Waters Chromatography,
Milford, MA, USA).
System III: An L-6000 pump (Hitachi Ltd., Tokio, Japan), an SPD-6AV UV-VIS
detector (Shimadzu Corporation, Japan) and Borwin data software (Merck, Darmstadt,
Germany).
All of the HPLC systems were equipped with a Rheodyne 7125 injector with a 20-
μL loop (Rheodyne, Cotati, CA, USA).
A Thermo Orion 420 pH-meter was employed for pH measurements.
The columns were thermostated in a water bath with thermostat and a cooling-
heating thermostat. The accuracy of temperature adjustment was ±0.1 °C.
The chromatographic system was conditioned by passing the eluent through the
column until a stable baseline signal and reproducible retention factors were obtained for
the subsequent injections. This procedure was always followed when a new mobile phase
or temperature was chosen.
3.2. Applied columns
Crown ether-based CSPs: (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid-based
CSPs, 150 × 4.6 mm I.D., 5 μm particle size.
Macrocyclic glycopeptide-based CSPs: teicoplanin-containing Chirobiotic T and
T2, teicoplanin aglycone-containing Chirobiotic TAG, vancomycin-containing Chirobiotic
V, vancomycin aglycone-containing Chirobiotic VAG and ristocetin A-containing
Chirobiotic R, 250 × 4.6 mm I.D., 5 μm particle size.
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3.3. Chemicals and reagents
The applied methanol (MeOH), ethanol (EtOH), propan-1-ol (PrOH) and propan-2-
ol (IPA) of HPLC grade were purchased from Merck (Darmstadt, Germany). Glacial acetic
acid (AcOH) was from Scharlau Chemie S. A. (Barcelona, Spain). Triethylamine (TEA),
trifluoracetic acid (TFA), phosphoric acid (H3PO4), perchloric acid (HClO4), sulfuric acid
(H2SO4) and sodium hydroxide, of analytical reagent grade were from Merck. Milli-Q
water was further purified by filtering it on a 0.45 μm filter, type HV, Millipore
(Molsheim, France). 0.1% Triethylammonium acetate (TEAA) buffer was prepared by
dissolving 750 μL of TEA in 750 mL of water, and adjusting the pH with AcOH to 4.1.
Mobile phases were prepared by mixing the indicated volumes of solvents. Stock
solutions of analytes (1 mg mL-1) were prepared by dissolution in the starting mobile
phase.
3.4. Investigated compounds
3.4.1. Monoterpene-based -amino acids
The investigated monoterpene-based -amino acids were prepared [128-131] at the
Institute of Pharmaceutical Chemistry in Szeged (Fig. 11). Their IUPAC names are
presented in the Appendix.
Figure 11. Structures of monoterpene-based -amino acids
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3.4.2. Isoxazoline-fused 2-aminocyclopentanecarboxylic acids
These compounds (Fig. 12) were prepared [132,133] at the Institute of
Pharmaceutical Chemistry in Szeged. Their IUPAC names are presented in the
Appendix.
Figure 12. Structures of isoxazoline-fused 2-aminocyclopentanecarboxylic acid analogues
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4. RESULTS AND DISCUSSION
4.1. Separation of monoterpene-based -amino acids on macrocyclic
glycopeptide-based CSPs
These compounds possess a monoterpene-based skeleton. Analogues 4 and 5 bear
one methyl group on position 2 or 4. In the case of analogue 3, the locations of the
carboxyl and amino group are opposite. These differences result in different steric effects
and influence the hydrophobicity, bulkiness and rigidity of the molecules, depending on
how their atoms are linked and how capable they are of different interactions with the
selector.
4.1.1. Effects of pH
First of all, the effects of pH on the separation were investigated in the acidic pH
range from 6.50 to 4.00 in the 0.1% aqueous TEAA/MeOH = 60/40 (v/v) eluent system on
analyte 4 (Fig. 13). With increasing pH, the retention factors decreased on Chirobiotic T,
while the selectivity increased slightly and the resolution considerably. Similar results were
obtained by Armstrong et al. [60] on a teicoplanin CSP for analytes with free carboxylic
acid groups. The pH that produced the highest  also yielded the best resolution. The
discontinuities in k’,  and RS at low pH are most probably due to the protonation on the
teicoplanin CSP and analyte. Protonation of teicoplanin either directly affects the
coulombic or dipolar interactions between the analyte and CSP, or indirectly influences the
separation by changing the conformation of the selector.
4 5 6 7
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Figure 13. Influence of the pH on the chromatographic parameters for analyte 4.
Chromatographic conditions: column, Chirobiotic T; mobile phase, 0.1% TEAA (pH =
4.1)/MeOH = 60/40 (v/v); flow rate, 0.5 mL min-1; detection, 210 nm
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4.1.2. Effects of MeOH as alcohol modifier
All the compounds were evaluated with different mobile phases, the eluent
composition being varied between 0.1% TEAA (pH=4.1)/MeOH = 98/2, 90/10, 80/20,
60/40, 40/60, 20/80, 10/90, 0/100 (v/v) and MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v)
(Table 1). For comparison purposes and to simplify the presentation, Table 1 lists only the
chromatographic results obtained at some mobile phase compositions. With the same
mobile phase composition, the retention factors were lower on the teicoplanin CSPs (T and
T2) than on the aglycone CSP (TAG) (except for analyte 3 in some cases). The native
teicoplanin phase (Chirobiotic T) exhibited intermediate k’ values. Similar trends, with
higher k’ values on the teicoplanin aglycone-containing CSP than on native teicoplanin,
were observed by D’Acquarica et al. [134], Berthod et al. [135] and Péter et al.
[62,136,137] for unusual -amino acids and cyclic -amino acids. Comparison of the T
and T2 columns revealed that the retention factors on Chirobiotic T were somewhat larger
(except for analytes 2 and 3 at 100% MeOH) (Table 1). Slightly higher k’ values on
Chirobiotic T2 than on Chirobiotic T were observed by Péter et al. [137] for 3-
homoamino acids.
The effects of the MeOH content of the mobile phase were investigated on all
macrocyclic glycopeptide-based columns, but on the Chirobiotic V, VAG and R columns
the values of selectivity () and resolution (RS) were very low. The best resolution (RS =
1.00) was achieved on Chirobiotic R for analyte 4 in the 0.1% TEAA (pH=4.1)/MeOH =
10/90 (v/v) mobile phase. As concerns the Chirobiotic V and VAG columns, the k’ values
on VAG were larger in all cases than those on V, similarly as for the T and TAG columns.
For the dependence of the chromatographic data on the MeOH concentration in the
mobile phase, in most cases a U-shaped retention curve was observed for all analytes (the
only exception was analyte 3 on the Chirobiotic T and T2 columns). At higher water
content, the retention factor increased with increasing water content, which was probably
due to enhanced hydrophobic interactions between the analyte and the CSP in the water-
rich mobile phases (Table 1). In the RP mode, one of the most important interactions
between the analyte and the CSP is the hydrophobic interaction inside the basket of the
glycopeptide. Here, an increase in k’ at high water content was observed for all analogues
(Table 1). When the MeOH content of the mobile phase exceeded ~50%, the retention
factor increased (an exception was analyte 3 on the Chirobiotic T and T2 columns).
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Table 1. Chromatographic data, retention factor of first-eluted enantiomer (k1’), separation
factor (), resolution (RS) and configuration of the first-eluted enantiomer of monoterpene-
based 2-aminocarboxylic acids on different macrocyclic glycopeptide-based columns
Analyte Column
Mobile phase
TEAA/MeOH
(v/v), a
MeOH/AcOH/TEA
(v/v/v), b
k1’  RS
Configuration
of the first-
eluted
enantiomer
1
T
90/10, a 3.48 1.14 1.27
1R,2R,3S,5R
40/60, a 1.98 1.08 0.72
10/90, a 2.65 1.15 1.74
0/100, a 4.18 1.19 1.85
100/0.1/0.1, b 3.05 1.24 1.57
T2
90/10, a 3.21 1.00 0.00
40/60, a 1.59 1.12 1.24
10/90, a 2.00 1.16 1.40
0/100, a 2.67 1.19 1.17
100/0.1/0.1, b 2.01 1.00 0.00
TAG
90/10, a 6.92 1.00 0.00
40/60, a 3.74 1.15 1.79
10/90, a 4.89 1.22 1.63
0/100, a 6.61 1.23 1.13
100/0.1/0.1, b 3.88 1.00 0.00
2
T
90/10, a 3.28 1.00 0.00
1R,2R,3R,5R40/60, a 2.30 1.04 0.39
10/90, a 3.65 1.06 0.80
0/100, a 4.73 1.08 0.90
100/0.1/0.1, b 3.39 1.08 0.56 1S,2S,3S,5S
T2
90/10, a 3.13 1.18 1.35
1R,2R,3R,5R40/60, a 2.23 1.03 0.2710/90, a 3.35 1.05 0.51
0/100, a 5.98 1.06 0.60
100/0.1/0.1, b 2.32 1.09 0.42 1S,2S,3S,5S
TAG
90/10, a 7.63 1.19 1.06
1R,2R,3R,5R40/60, a 4.88 1.00 0.0010/90, a 7.05 1.00 0.00
0/100, a 8.96 1.02 1.53
100/0.1/0.1, b 4.09 1.00 0.00 1S,2S,3S,5S
3
T
90/10, a 11.95 1.00 0.00
1R,2R,3R,5S
40/60, a 7.49 1.00 0.00
10/90, a 3.68 1.15 1.34
0/100, a 1.30 1.48 3.49
100/0.1/0.1, b 3.17 1.32 2.67
T2
90/10, a 10.11 1.00 0.00
40/60, a 2.43 1.12 0.62
10/90, a 2.00 1.22 1.22
0/100, a 1.80 1.29 1.97
100/0.1/0.1, b 2.84 1.09 0.95
21
Table 1 (continued)
Analyte Column
Mobile phase
TEAA/MeOH
(v/v), a
MeOH/AcOH/TEA
(v/v/v), b
k1’  RS
Configuration
of the first-
eluted
enantiomer
3 TAG
90/10, a 11.90 1.07 0.81
1R,2R,3R,5S
40/60, a 5.96 1.08 0.35
10/90, a 4.75 1.29 1.83
0/100, a 4.84 1.32 2.76
100/0.1/0.1, b 3.13 1.35 1.97
4
T
90/10, a 3.28 1.34 2.95
1S,2S,3R,5S
40/60, a 1.79 1.08 0.66
10/90, a 2.17 1.15 1.32
0/100, a 3.29 1.22 1.38
100/0.1/0.1, b 2.07 1.30 2.31
T2
90/10, a 3.22 1.20 1.78
40/60, a 1.40 1.12 1.07
10/90, a 1.52 1.27 1.78
0/100, a 1.90 1.45 1.92
100/0.1/0.1, b 1.25 1.65 2.11
TAG
90/10, a 9.68 1.06 0.48
40/60, a 3.86 1.17 1.68
10/90, a 3.25 1.25 1.80
0/100, a 4.63 1.30 1.83
100/0.1/0.1, b 2.69 1.49 3.27
5
T
90/10, a 4.40 1.00 0.00
1R,2R,3S,4R,5R
40/60, a 1.91 1.00 0.00
10/90, a 2.44 1.05 0.67
0/100, a 3.69 1.09 0.81
100/0.1/0.1, b 2.51 1.12 1.78
T2
90/10, a 4.38 1.12 0.89
40/60, a 1.59 1.08 0.74
10/90, a 1.90 1.10 0.86
0/100, a 2.24 1.14 0.90
100/0.1/0.1, b 1.54 1.17 0.75
TAG
90/10, a 10.93 1.07 0.66
40/60, a 4.49 1.09 0.81
10/90, a 3.86 1.11 1.09
0/100, a 5.34 1.16 1.11
100/0.1/0.1, b 2.88 1.25 1.36
Chromatographic conditions: columns, T, Chirobiotic T, T2, Chirobiotic T2, TAG,
Chirobiotic TAG; mobile phase, a, 0.1% TEAA (pH=4.1)/MeOH (v/v), b,
MeOH/AcOH/TEA (v/v/v); temperature, ambient; flow rate, 0.5 mL min-1; detection, 210
nm
This suggests that the separation may be controlled rather by the hydrophilic interaction
chromatography (HILIC) than by the RP mechanism at high MeOH content. The existence
of HILIC may relate to the change in solvation of the stationary phase and the strength of
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polarity. Besides the stationary phase, the water layer is thinned by increasing alcohol
content, and therefore the polar unit of the analyte interacts more strongly with the selector
and the retention is increased.
For analyte 3 on Chirobiotic T and T2, a continuous increase in k’ was observed
with increasing water content. This different behaviour of analyte 3 may be due to the
different positions of the carboxyl and amino groups, resulting in a difference in the steric
interaction with the selectors containing carbohydrate units (Chirobiotic T and T2).
As regards the effect of a change of MeOH content on the changes in the separation
factors () and resolution (RS), no general rules could be observed.
Application of the MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v) mobile phase system
generally resulted in lower retention than on the application of 100% MeOH (except for
analyte 3 on Chirobiotic T and T2). However, for analytes 4 and 5, despite the lower k’
values, higher  and RS values were obtained, indicating that the chiral discrimination
improved in the PI mode when the carboxyl and amino groups were in positions 2 and 3,
respectively, or methyl substitution resulted in a highly constrained analogue (Table 1).
4.1.3. Influence of the structures of the compounds
The structures of the compounds affected the chiral recognition. In the RP mode in
water-rich mobile phases, analyte 3 exhibited large k1’ values, which were not
accompanied by high resolution. At high water content, the non-specific hydrophobic
interaction resulted in high retention without chiral recognition. The  value reached its
maximum at high MeOH content. Molecules 4 and 5 containing a methyl group are
sterically constrained, resulting in most cases in higher  (and RS) values as compared with
analytes 1 and 2. Interestingly, it seems that the position of the methyl group on the
cycloalkane skeleton (position 2 or 4) produced a considerable effect on  and RS; the
more constrained analyte 4 gave higher  and RS values than those of analyte 5.
Baseline resolution was achieved in all cases, as shown in selected chromatograms
in the Appendix.
4.1.4. Effects of temperature on the chromatographic parameters
In order to investigate the effects of temperature on the chromatographic
parameters, a variable-temperature study was carried out over the temperature range 10-40
°C (in 5 or 10 °C increments) on Chirobiotic T and TAG columns. Experimental data for
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the mobile phase 0.1% TEAA (pH = 4.1)/MeOH = 10/90 (v/v) are listed in Table 2. A
comparison of the retention factors in Table 2 reveals that all of the recorded values
decreased with increasing temperature (similar tendencies were measured at other mobile
phase compositions). It is evident that an increase in separation temperature lowers the
separation factor, . However, for analyte 3 on the T column,  (and also RS) increased
with increasing temperature (Table 2). Increasing temperature may improve the peak
symmetry and efficiency, and therefore the resolution may also improve.
Since the effect of temperature on the separation was complex, an extensive study
relating to the thermodynamics of the enantiomer separation was carried out. In order to
calculate the thermodynamic parameters and to acquire information towards an
understanding of the enantiomeric retention, the selectivity and the mechanism on these
CSPs, van’t Hoff plots were constructed [Eq. (12)].
Table 2. Retention factor of first-eluting enantiomer (k’), separation factor () and
resolution (Rs) of enantiomers of monoterpene-based 2-aminocarboxylic acids 1-5 as a
function of temperature
Analyte Columns k1’, ,RS
Temperature (°C)
10 15 20 30 40
1
T
k1’ 4.49 4.18 4.05 3.58 3.21
 1.13 1.12 1.12 1.11 1.10
RS 1.66 1.64 1.51 1.59 1.62
TAG
k1’ 6.79 6.29 5.81 5.09 4.63
 1.17 1.16 1.15 1.14 1.12
RS 1.46 1.48 1.66 1.71 1.88
2
T
k1’ 5.84 5.54 5.31 4.97 4.63
 1.04 1.03 1.03 1.02 1.01
RS 0.53 0.50 0.39 0.38 0.46
TAG
k1’ 10.66 9.96 9.65 8.68 8.12
 1.00 1.00 1.00 1.00 1.00
RS 0.00 0.00 0.00 0.00 0.00
3
T
k1’ 7.30 6.26 5.66 4.76 4.05
 1.09 1.11 1.12 1.14 1.17
RS 0.70 0.81 0.85 1.07 1.09
TAG
k1’ 13.37 10.21 8.09 6.18 4.08
 1.20 1.17 1.13 1.09 1.04
RS 1.97 1.33 1.04 0.75 0.33
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Table 2 (continued)
Analyte Columns k1’, ,RS
Temperature (°C)
10 15 20 30 40
4
T
k1’ 3.74 3.51 3.35 3.06 2.73
 1.13 1.12 1.11 1.10 1.09
RS 1.27 1.28 1.30 1.32 1.35
TAG
k1’ 5.18 4.86 4.48 4.13 3.75
 1.20 1.19 1.18 1.17 1.16
RS 1.47 1.74 1.84 1.95 2.09
5
T
k1’ 4.29 4.02 3.77 3.43 3.08
 1.05 1.05 1.04 1.04 1.03
RS 0.72 0.67 0.61 0.48 0.38
TAG
k1’ 6.23 5.82 5.64 4.89 4.37
 1.12 1.11 1.10 1.09 1.07
RS 1.24 1.25 1.30 1.29 1.22
Chromatographic conditions: column, T, Chirobiotic T, TAG, Chirobiotic TAG; mobile
phase, 0.1% TEAA (pH = 4.1)/MeOH = 10/90 (v/v); temperature, ambient; flow rate, 0.5
mL min-1; detection, 210 nm
The H° and S°* values calculated from the slopes and intercepts of the plot of
Eq. (12) for the enantiomers on both columns were negative (Table 3). Further, H° and
S°* for the first-eluting enantiomer were always less negative than those for the second-
eluting enantiomer (analyte 2 was not separated on the Chirobiotic TAG column). Since
the second-eluting enantiomers have more negative S°* values, they probably have fewer
degrees of freedom on the CSP, i.e. they are held at more points or are less able to move or
rotate. It is widely accepted that both enantiomers show the same non-specific interactions
and the more strongly retained one is subjected to additional stereospecific interactions
with chiral centres. It was also observed that H°1 and H°2 and in parallel S°*1 and
S°*2 for the native teicoplanin-containing column were in most cases less negative than
those for the aglycone-containing TAG column. The TAG CSP without sugar moieties
may promote the interaction between the analyte and the CSP.
Of the five analogues, analyte 2 exhibited the smallest, and analyte 3 the largest –
H° and –S°* values. The positions (2 and 3) of the amino and carboxyl groups and the
trans configuration in 2 probably inhibits the fitting and orientation in the cavity (the sugar
units on the Chirobiotic T column improve the chiral recognition, while on TAG no
separation was observed), and the separation was thermodynamically less favourable. The
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largest –H° and –S°* values for 3 indicated that, despite of the trans configuration, the
steric arrangement of the carboxyl and amino groups may promote the steric/rigidity effect
or polar interactions with the CSP and the largest –H° and –S°* values were obtained.
The difference in the changes of enthalpy, (H°) and entropy, (S°), are also
presented in Table 3. The –(H°) values ranged from -1.5 to 3.3 kJ mol-1. The
interactions of 3 with the TAG stationary phase were characterized by the highest negative
(H°) value, while analyte 3 on the T column exhibited a positive (H°) value. The
trends in the change of –(S°) showed that analyte 3 on TAG displayed the largest
negative entropies and the –(S°) values ranged from -6.1 to 10.2 J mol-1 K-1 (Table 3).
For all analytes, the –(S°) values are controlled by the difference in the number of
degrees of freedom between the stereoisomers on the CSP, and mainly by the number of
solvent molecules released from solvating both the chiral selector and the analyte when the
analyte is associated with the CSP.
The thermodynamic parameter –(G°) suggests that the aglycone induces highly
efficient binding to the selector, as reflected by the large negative (S°) values for 1, 3, 4
and 5, while for analytes 2 and 3 the carbohydrate moieties may promote the interaction of
the enantiomers (on Chirobiotic TAG, the enantiomers of analyte 2 were not separable at
this eluent composition). For analyte 3 on the T column, the positive (S°) value
compensates the positive (H°) and resulted in a relatively high –(G°) value. Native
teicoplanin, containing more chiral centres ensures more interaction sites for compounds
resulting in more negative –(G°) values; in this temperature range, enantioresolution is
entropically driven, and the selectivity increases with increasing temperature. The complex
formation proceeding via multiple intermolecular interactions was generally exothermic
and the corresponding entropic contribution was also negative.
From the result, temperature Tiso (Table 3) was calculated at which the
enantioselectivity is lost and the elution sequence changes. In most cases, Tiso was above
50 °C, but for analyte 3 on Chirobiotic T it was -26 °C. These results indicate that for most
of the compounds a cold enantioseparation should be recommended for the best resolution,
except for analyte 3 on the T column, where positive enthalpy and entropy changes were
observed.
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Table 3. Thermodynamic parameters, H, S, (H), (S), (G), correlation coefficients (R2) and temperatures Tiso of analytes 1-5 on
Chirobiotic T and TAG columns
Analyte Column Stereo-isomer
-H
(kJ mol-1)
-S
(J mol-1 K-1)
Correlation
coefficient
(R2)
-(H)
(kJ mol-1)
-(S)
(J mol-1 K-1)
-(G)298K(kJ mol-1)
Tiso
(C)
1
T 1 8.1 16.1 0.9946 0.61 1.17 0.30 2482 8.7 17.3 0.9950
TAG 1 9.5 17.7 0.9949 0.98 2.16 0.35 1792 10.5 19.8 0.9960
2
T 1 5.6 5.1 0.9966 0.61 1.86 0.06 572 6.2 7.0 0.9977
TAG 1 6.7 3.9 0.9921 0.00 0.00 0.00 -2 6.7 3.9 0.9921
3
T 1 14.1 33.5 0.9911 -1.50 -6.05 0.30 -262 12.6 27.4 0.9903
TAG 1 27.9 77.3 0.9901 3.31 10.22 0.25 502 31.2 87.6 0.9910
4
T 1 7.6 15.7 0.9960 0.91 2.21 0.25 1392 8.5 17.9 0.9961
TAG 1 7.8 14.1 0.9906 0.79 1.30 0.40 3382 8.6 15.4 0.9922
5
T 1 8.0 16.1 0.9985 0.54 1.47 0.10 932 8.5 17.6 0.9985
TAG 1 8.8 15.7 0.9924 1.02 2.67 0.20 1082 9.8 18.4 0.9944
Mobile phase, 0.1% TEAA (pH = 4.1)/MeOH = 10/90 (v/v); S = S+R ln, where  is the inverse of the phase ratio; R2, correlation coefficient of
the van’t Hoff plot, ln k – 1/T curves; Tiso,, temperature of ln k – 1/T curves where the enantioselectivity balances out.
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4.2. Enantioseparation of isoxazoline-fused 2-aminocyclopentane-
carboxylic acid analogues on macrocyclic antibiotic-based CSPs
These analytes possess an isoxazoline-fused cyclopentane skeleton. Besides
carboxy and primary amino groups, analogues 6 and 8 bear a methyl group on position 3,
and analytes 7 and 9 an ethyl group on position 3.
4.2.1. Effects of the nature of the mobile phase
All data relating to the separation of the analytes, including the k’, , RS and elution
sequence for each analyte on the five different Chirobiotic columns, are given in Table 4.
All the compounds mentioned in Table 4 were evaluated with different mobile phases,
with eluent compositions varying between 0.1% TEAA (pH = 4.1)/MeOH = 98/2 and
10/90 (v/v). For comparison purposes and to simplify the presentation, Table 4 lists only
the chromatographic results obtained at some mobile phase compositions.
In most cases, the retention factors were lower on the Chirobiotic T2 column
(except for analytes 6c,6d and 7c,7d) than on native teicoplanin. Similar results were
observed in this study for monoterpene-based analogues and -amino acids [62,137-140].
As regards the dependence of the retention factors on the MeOH content, in most
cases a U-shaped curve was observed for all analytes. The k’ values increased with
increasing water content (hydrophobic interactions) and when the MeOH content of the
mobile phase exceeded ~50% the retention factors also increased (HILIC).
The tendencies of the  and RS values were the same in most cases. For 6a-6d and
7a-7d, the resolutions were highest on Chirobiotic TAG (except for analytes 7a,7b). The
vancomycin-based columns were not able to separate the enantiomers of analytes 6a-6d
and 7a-7d. On the other hand, these columns gave the best selectivity and resolution values
for analytes 8a-8d and 9a-9d (mainly for cis analogues). In the comparison of the
Chirobiotic V and VAG columns, the results were the same as in the case of the T and
TAG selectors; the retentions were higher on the aglycone-containing CSP.
Determination of the elution sequence is often a very important task. The
proportion of MeOH did not affect the elution sequence. For 6c-6d and 7c-7d, the elution
sequence was changed when the TAG column was used, but the same result was observed
for all of compounds 8 and 9. Between the V and VAG columns, no change in elution
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sequence was observed. In the case of cis analytes, the elution sequence on V and VAG
was the same as that on TAG.
Table 4. Retention factors of the first-eluting enantiomer (k1’), separation factors (α),
resolutions (RS) and elution sequences of regio- and stereoisomers of isoxazoline-fused
cispentacin analogues in RP mode
Compound Column
Mobile phase
TEAA/MeOH
(v/v)
k1'  RS Elutionsequence
6a,6b T 90/10 2.63 1.00 0.00 -
60/40 2.31 1.01 0.20 a<b
10/90 4.76 1.07 0.80 a<b
T2 90/10 0.93 1.10 0.70 a<b
60/40 0.91 1.13 1.00 a<b
10/90 2.96 1.16 1.65 a<b
TAG 90/10 4.31 1.19 1.80 a<b
60/40 2.73 1.26 2.25 a<b
10/90 4.76 1.33 3.25 a<b
6c,6d T 90/10 1.85 1.00 0.00 -
10/90 7.51 1.01 0.20 d<c
T2 90/10 1.39 1.00 0.00 -
10/90 8.16 1.04 0.65 d<c
TAG 90/10 3.26 1.06 0.70 c<d
10/90 8.20 1.02 0.20 c<d
7a,7b T 90/10 1.88 1.06 0.65 a<b
60/40 1.77 1.09 0.85 a<b
10/90 3.75 1.07 1.00 a<b
T2 90/10 1.07 1.14 0.80 a<b
60/40 0.95 1.18 1.20 a<b
10/90 2.28 1.24 2.60 a<b
TAG 90/10 5.63 1.18 1.85 a<b
60/40 2.92 1.30 2.25 a<b
10/90 4.65 1.18 1.90 a<b
7c,7d T 90/10 2.55 1.00 0.00 -
10/90 6.52 1.00 0.00 -
T2 90/10 1.64 1.00 0.00 -
10/90 6.64 1.03 0.60 d<c
TAG 90/10 4.98 1.10 1.40 c<d
60/40 4.52 1.09 1.55 c<d
10/90 6.95 1.03 0.40 c<d
8a,8b T 90/10 2.09 1.00 0.00 -
10/90 5.01 1.17 1.45 a<b
T2 90/10 1.11 1.00 0.00 -
10/90 3.66 1.00 0.00 -
TAG 90/10 6.09 1.09 1.00 b<a
10/90 5.66 1.09 0.85 b<a
V 90/10 0.30 1.15 0.55 b<a
10/90 0.98 1.36 2.95 b<a
VAG 90/10 0.57 1.18 1.10 b<a
10/90 1.18 1.31 2.70 b<a
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Table 4 (continued)
Compound Column
Mobile phase
TEAA/MeOH
(v/v)
k1'  RS Elutionsequence
8c,8d T 90/10 1.90 1.13 1.30 d<c
10/90 5.71 1.02 0.30 d<c
T2 90/10 1.07 1.16 1.00 d<c
10/90 3.23 1.14 1.65 d<c
TAG 90/10 3.18 1.06 0.60 c<d
10/90 5.75 1.24 2.15 c<d
V 90/10 0.16 1.25 0.60 d<c
10/90 0.78 1.13 0.80 d<c
VAG 90/10 0.54 1.00 0.00 -
10/90 1.63 1.06 0.60 d<c
9a,9b T 90/10 2.64 1.00 0.00 -
10/90 4.82 1.17 1.65 a<b
T2 90/10 1.10 1.00 0.00 -
10/90 3.72 1.00 0.00 -
TAG 90/10 7.86 1.09 0.90 b<a
10/90 4.91 1.18 2.15 b<a
V 90/10 0.45 1.09 0.45 b<a
10/90 0.92 1.35 2.60 b<a
VAG 90/10 0.81 1.16 1.35 b<a
10/90 1.08 1.31 3.00 b<a
9c,9d T 10/90 4.50 1.08 1.10 d<c
T2 10/90 2.88 1.14 1.55 d<c
TAG 10/90 4.60 1.27 2.50 c<d
V 10/90 0.71 1.08 0.50 d<c
VAG 10/90 1.47 1.05 0.55 d<c
Chromatographic conditions: selectors and columns. T and T2, teicoplanin, Chirobiotic T
and T2; TAG, teicoplanin aglycon, Chirobiotic TAG; V, vancomycin, Chirobiotic V;
VAG, vancomycin aglycon, Chirobiotic VAG; mobile phase, 0.1% TEAA (pH =
4.1)/MeOH (v/v); temperature, ambient; flow rate, 0.5 mL min-1; detection, 210 nm
On comparison of the PI and PO modes, the retention factors were lower in the PI
mode (except for analytes 7a,7b on T2, 8a,8b on T and TAG, and 9a,9b on the TAG
column). In a few cases, the lower retention factors resulted in higher selectivity and
resolution values in the PI mode (Table 5). For vancomycin-based CSPs, the results were
the same as in the RP mode.
The differences in the PO and PI modes can also be observed for the elution
sequence. In cases of 6a-6d and 7a-7d as analytes, the elution sequence in the PI mode was
the opposite of that in the PO mode on the Chirobiotic T column. In most cases, the
sequence was not changed (except for analytes 9c,9d) on the T2 CSP. On the V and VAG
columns, the elution sequence was the same for all analytes.
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Table 5. Retention factors of the first-eluting enantiomer (k1’), separation factors (α),
resolutions (RS) and elution sequences of regio- and stereoisomers of isoxazoline-fused
cispentacin analogues in PO and PI modes
Compound Column
Mobile phase
MeOH (100%)
MeOH/AcOH/TEA
(v/v/v)
k1'  RS Elutionsequence
6a,6b T 100 9.29 1.11 0.90 b<a
100/0.1/0.1 7.78 1.03 0.35 a<b
T2 100 5.23 1.16 0.90 a<b
100/0.1/0.1 4.91 1.00 0.00 -
TAG 100 11.91 1.05 0.30 b<a
100/0.1/0.1 8.16 1.00 0.00 -
6c,6d T 100 14.70 1.04 0.40 d<c
100/0.1/0.1 7.41 1.04 0.95 c<d
T2 100 16.65 1.04 0.65 d<c
100/0.1/0.1 7.78 1.07 0.30 d<c
TAG 100 7.48 1.00 0.00 -
100/0.1/0.1 7.45 1.00 0.00 -
7a,7b T 100 7.30 1.00 0.00 -
100/0.1/0.1 6.66 1.02 0.25 a<b
T2 100 4.19 1.24 1.40 a<b
100/0.1/0.1 4.91 1.21 1.20 a<b
TAG 100 12.91 1.00 0.00 -
100/0.1/0.1 11.01 1.26 1.20 a<b
7c,7d T 100 16.59 1.00 0.00 -
100/0.1/0.1 6.41 1.00 0.00 -
T2 100 14.49 1.17 1.00 d<c
100/0.1/0.1 9.59 1.03 0.40 d<c
TAG 100 10.14 1.00 0.00 -
100/0.1/0.1 7.38 1.00 0.00 -
8a,8b T 100 7.27 1.46 3.75 a<b
100/0.1/0.1 9.13 1.21 1.65 a<b
T2 100 7.16 1.00 0.00 -
100/0.1/0.1 5.92 1.03 0.25 b<a
TAG 100 11.63 1.29 1.45 a<b
100/0.1/0.1 15.49 1.08 0.50 b<a
V 100 1.95 1.40 2.70 b<a
100/0.1/0.1 1.60 1.44 3.05 b<a
VAG 100 2.41 1.34 3.50 b<a
100/0.1/0.1 1.73 1.36 3.10 b<a
8c,8d T 100 11.76 1.03 0.25 c<d
100/0.1/0.1 7.85 1.05 0.45 c<d
T2 100 5.57 1.29 2.00 d<c
100/0.1/0.1 3.19 1.23 1.35 d<c
TAG 100 14.75 1.06 0.35 c<d
100/0.1/0.1 6.00 1.09 1.25 c<d
V 100 1.74 1.14 1.10 d<c
100/0.1/0.1 1.50 1.00 0.00 -
VAG 100 3.45 1.08 0.75 d<c
100/0.1/0.1 1.58 1.14 0.95 d<c
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Table 5 (continued)
Compound Column
Mobile phase
MeOH (100%)
MeOH/AcOH/TEA
(v/v/v)
k1'  RS Elutionsequence
9a,9b T 100 10.06 1.20 1.70 a<b
100/0.1/0.1 7.67 1.11 0.95 a<b
T2 100 7.08 1.00 0.00 -
100/0.1/0.1 6.46 1.00 0.00 -
TAG 100 9.25 1.24 0.90 b<a
100/0.1/0.1 11.07 1.25 1.50 b<a
V 100 1.81 1.38 2.20 b<a
100/0.1/0.1 1.47 1.41 3.30 b<a
VAG 100 2.18 1.34 3.15 b<a
100/0.1/0.1 1.49 1.38 3.10 b<a
9c,9d T 100 8.76 1.09 0.65 d<c
100/0.1/0.1 5.74 1.12 1.15 d<c
T2 100 4.90 1.26 1.75 d<c
100/0.1/0.1 4.54 1.06 0.40 c<d
TAG 100 13.94 1.03 0.30 c<d
100/0.1/0.1 6.54 1.14 0.50 c<d
V 100 1.51 1.09 0.45 d<c
100/0.1/0.1 1.09 1.12 1.30 d<c
VAG 100 3.24 1.06 0.50 d<c
100/0.1/0.1 1.28 1.10 0.55 d<c
Chromatographic conditions: selectors and columns. T and T2, teicoplanin, Chirobiotic T
and T2; TAG, teicoplanin aglycone, Chirobiotic TAG; V, vancomycin, Chirobiotic V;
VAG, vancomycin aglycon, Chirobiotic VAG; mobile phase, 0.1% TEAA (pH =
4.1)/MeOH (v/v); temperature, ambient; flow rate, 0.5 mL min-1; detection. 210 nm
4.2.2. Effects of the structures of the molecules
The structures of the analytes also influenced the chiral recognition. Generally, the
 and RS values were better in the case of cis compounds for all five columns. However,
there was no separation on the V and VAG columns for analytes 6a-6d and 7a-7d, which
can be attributed to the blocking of enantioselective interactions due to the unfavourable
position of the R substituent. As shown in Tables 4 and 5, the enantioseparation depended
on the positions of the amino and carboxyl groups; the cis enantiomers probably fit better
into the basket, resulting in stronger interactions and better separations.
The position of the methyl or ethyl group also affected the  and RS values. For
both  and RS, better values were obtained on the teicoplanin or teicoplanin aglycone-
containing CSPs in the case of the methyl-containing analogues: in most cases,
enantiomers 6a,6b were better separated than 8a,8b, while 8c,8d were better separated
than 6c,6d. This observation also held true for the ethyl-containing analytes.
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4.2.3. Separation of four enantiomers of isoxazoline-fused cispentacin analogues
Since the biological activities of isoxazoline-fused 2-aminocyclopentanecarboxylic
acid analogues depend strongly on their configurations, it is a basic task to separate and
identify not only the enantiomers, but also the diastereomers in one chromatographic run.
The data listed in Table 4 reveal that separation of the four stereoisomers could be
achieved in only a few cases. To attain separation of the four stereoisomers in one
chromatographic run, the separation was optimized by variation of the CSPs and mobile
phase composition. Table 6 illustrates the enantioseparation of all four stereoisomers of
isoxazoline-fused 2-aminocyclopentanecarboxylic acid analogues. Unfortunately, no
chromatographic condition was found for the baseline separation of 6a-6d and 9a-9d in
one chromatographic run.
Table 6. Chromatographic data, retention factors and resolutions for the separation of four
stereoisomers of isoxazoline-fused cispentacin derivatives on Chirobiotic TAG, VAG and
V columns
Analyte Column MobilePhase k’1 k’2 k’3 k’4 RS1 RS2 RS3
Elution
sequence
6 TAG a 2.73 3.45 3.95 4.13 3.10 2.05 0.80 a<b<c<d
7 TAG b 2.89 3.28 3.58 4.05 1.95 1.40 2.15 a<b<c<d
8 VAG c 2.53 2.93 3.21 3.50 1.95 1.45 1.80 b<d<c<a
9 V d 1.27 1.43 1.83 2.67 0.90 1.95 3.30 d<c<b<a
Chromatographic conditions: mobile phase, a, 0.1% TEAA (pH = 4.1)/MeOH = 60/40
(v/v), b, 0.1% TEAA (pH = 4.1)/MeOH (v/v) = 80/20 (v/v); c, MeOH, 100%, d,
MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v); temperature, 25 °C for analytes 6 and 7, 10 °C
for analytes 8 and 9; flow rate, 0.5 mL min-1; detection, 210 nm
4.2.4. Effects of temperature on chiral recognition
A variable-temperature study was carried out on Chirobiotic T and TAG columns
over the temperature range 5-45 C (in 10 °C increments). The measurements were made
with the mobile phase 0.1% TEAA (pH = 4.1)/MeOH = 10/90 (v/v) system. For the
chromatographic data, all of the recorded values decreased with increasing temperature,
except for 8a,8b on the teicoplanin aglycone-containing CSP, where  (and RS) increased
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with increasing temperature. Increasing temperature may influence the peak symmetry and
efficiency, and therefore the resolution may also improve.
Thermodynamic parameters were obtained from van’t Hoff plots [Eq. (12)] in all
cases. The H° and S°* values were calculated from the slopes and intercepts of these
plots. In most cases, these values were more negative for the second-eluting enantiomer
(Fig. 14) (the exception was analytes 8a,8b on Chirobiotic TAG (Fig. 15)). It is likely that
the second-eluting enantiomers have fewer degrees of freedom on the CSP, i.e. they are
held at more points or are less able to move or rotate. In these cases, the enthalpy change
exceeded the degree of entropy change, and thus the change in Gibbs free energy was also
negative.
Figure 14. Temperature dependence of analytes 8a,8b on the Chirobiotic T column
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Figure 15. Temperature dependence of analytes 8a,8b on the Chirobiotic TAG column
The evolving interactions between the analytes and the CSP are therefore
exothermic. For 8a,8b on the Chirobiotic TAG CSP, the change in entropy dominated, and
the G° value was therefore positive (Fig. 16).
Smaller H° and S°* values were observed on the Chirobiotic T column than on
the aglycone-containing CSP (Table 7). This may be due to the lack of sugar moeties, and
this may promote the interactions between the CSP and the analyte. As shown in Table 7,
the enantiomers c,d exhibited smaller, and the enantiomers a,b larger -H° and -S°*
values on both CSPs. The trans configuration of the amino and carboxy groups in the c,d
enantiomer pairs may sterically inhibit their fit and orientation in the cavity, and the
separation was thermodynamically less favorable. The largest -H° and -S°* values for all
analytes on the TAG CSP indicate that separation on it was sterically favourable. Without
sugar units, the compounds fit better into the basket, where they form stronger interactions.
The differences in the changes in enthalpy and entropy, (H°) and (S°), are
also presented in Table 7. These values were calculated from Eq. (15), indicating whether
the enantioseparation was enthalpically or entropically driven. The thermodynamic
parameter -(G°) suggests that TAG induces highly efficient binding to the selector, as
reflected by the larger negative (G°) values for 6-9 on Chirobiotic TAG. For analytes 6-
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9 on both columns (with the exception of 8a,8b on Chirobiotic TAG), selector-selectand
complex formation proceeded via multiple intermolecular interactions and was generally
exothermic, with a corresponding negative entropic contribution.
The data were used to calculate the temperature Tiso, at which point the
enantioselectivity and the elution sequence changed (Table 7). In most cases, Tiso was
considerably higher than room temperature; enthalpically driven enantioseparation was
obtained. For 8a,8b on Chirobiotic TAG, Tiso was -15 C, positive (H°) and (S°)
were observed in the investigated temperature range, and the selectivity increased with
increasing temperature.
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Table 7. Thermodynamic parameters, H, S, (H), (S), (G), correlation coefficients (R2) and temperature Tiso of analytes 6-9 on
Chirobiotic T and TAG columns
Analyte Column Stereo-isomer
-H
(kJ mol-1)
-S
(J mol-1K-1)
Correlation
coefficient
(R2)
-(H)
(kJ mol-1)
-(S)
(J mol-1K-1)
-(G)288K(kJ mol-1)
Tiso
(C)
6a,6b
T 1 7.65 13.7 0.9961 1.21 3.71 0.14 54.72 8.87 17.41 0.9974
TAG 1 9.82 20.06 0.9949 3.54 9.53 0.80 98.42 13.36 29.59 0.9977
6c,6d
T 1 6.03 4.19 0.9940 0.66 2.21 0.02 36.32 6.38 5.33 0.9930
TAG 1 9.39 15.40 0.9976 0.17 0.40 0.98 146.82 9.56 15.80 0.9977
7a,7b
T 1 7.58 14.36 0.9953 1.56 4.71 0.20 57.92 9.14 19.07 0.9973
TAG 1 10.11 21.28 0.9942 2.14 5.80 0.47 95.72 12.25 27.07 0.9964
7c,7d
T 1 5.88 4.21 0.9985 0.61 2.04 0.02 36.42 6.21 5.26 0.9995
TAG 1 9.13 14.61 0.9952 0.20 0.48 0.06 151.72 9.33 15.09 0.9953
8a,8b
T 1 9.61 18.98 0.9952 3.18 9.37 0.48 66.22 12.79 28.35 0.9989
TAG 1 12.05 25.00 0.9980 -1.21 -4.67 0.13 -15.12 10.85 20.32 0.9969
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Table 7 (continued)
Analyte Column Stereo-isomer
-H
(kJ mol-1)
-S
(J mol-1K-1)
Correlation
coefficient
(R2)
-(H)
(kJ mol-1)
-(S)
(J mol-1K-1)
-(G)288K(kJ mol-1)
Tiso
(C)
8c,8d
T 1 6.37 6.95 0.9923 0.34 1.01 0.05 66.62 6.72 7.98 0.9926
TAG 1 9,07 17,62 0,9957 0,75 0,73 0,54 745,02 9,82 18,36 0,9966
9a,9b
T 1 9.60 19.59 0.9986 2.02 6.15 0.25 55.12 11.62 25.73 0.9993
TAG 1 10.86 23.52 0.9955 0.55 0.55 0.39 740.62 11.42 24.07 0.9956
9c,9d
T 1 6.05 7.19 0.9901 0.83 2.23 0.19 99.92 6.88 9.41 0.9927
TAG 1 8.21 13.90 0.9973 0.96 1.33 0.58 449.92 9.17 15.23 0.9979
Mobile phase, 0.1% TEAA (pH = 4.1)/MeOH = 10/90 (v/v); S = S + ln, where  is the inverse of the phase ratio; R2, is the correlation
coefficient of the van’t Hoff plot, ln k – 1/T curves; Tiso, the temperature of ln k – 1/T curves where the enantioselectivity balances out
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For 6c,6d and 7c,7d on the Chirobiotic T CSP, Tiso was 37 C. For 6c,6d on the
Chirobiotic T column with the 0.1% TEAA (pH = 4.1)/MeOH = 10/90 (v/v) mobile phase
composition, on increase of the temperature from 5 C to 55 C,  first decreased; then,
after a domain where no separation occurred,  slightly increased with increasing
temperature and the elution sequence changed (Fig. 16). In a domain around the
isoenantioselective temperature, separation of the enantiomers could not be attained.
0 10 20 30 40
c=d
dc
 = 1.04, T = 55°C
 = 1.00, T = 25°CA
tR (min)
 = 1.04, T = 5°C
d
c
Figure 16. Change of elution sequence on the Chirobiotic T column for analytes 6c,6d
This domain may be referred to as a temperature-induced blind zone in chiral
recognition [138]. Outside the blind zone, enthalpically or entropically driven
enantioseparation can be observed. It should be mentioned that peak inversions on
temperature changes have generally been observed only for separations with marginal
enantioselectivity [139-142].
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4.3. Separation of isoxazoline-fused cispentacin stereoisomers on chiral
crown ether-containing CSPs
The primary interaction in the course of chiral recognition is complex formation
between the protonated amino group of the analyte and the CSP. For these types of
columns, an acidic modifier may be added to the mobile phase to protonate the primary
amino group of the analyte. Stereoselective complexation of the resulting primary
ammonium ions (R-NH3+) inside the cavity of the crown ether ring of the CSP has been
suggested to be essential for chiral recognition (Fig. 8) [143]. Besides these interactions,
H-bonding, hydrophobic, dipole-dipole, steric, etc. interactions should likewise be taken
into account.
4.3.1. Effects of the nature and content of the alcholic modifier
On the three crown ether-based columns, the results of the separation of
enantiomers of isoxazoline-fused 2-aminocyclopentanecarboxylic acids were evaluated
with different mobile phases consisting of H2O/alcohol + 10 mM acid, where the alcohol
was MeOH, EtOH or IPA + 10 mM AcOH. Data relating to the separation of compounds,
including the retention factors, separation factors and resolutions for the analytes on the
three CSPs, are given in Table 8. To simplify the presentation and to reduce the huge
number of data, Table 8 basically lists only the columns and chromatographic results
obtained when H2O/MeOH = 90/10 or 5/95 (v/v) + 10 mM AcOH mobile phases were
applied, and for analytes 7a,7b and 7c,7d the dependence of the chromatographic data on
the alcohol content is depicted. In Table 8, for purposes of comparison, results are also
included where no separation occurred.
At a given mobile phase composition [H2O/alcohol = 90/10 or 30/70 (v/v)],
applying MeOH, EtOH or IPA as alcoholic modifier and 10.0 mM AcOH as acidic
modifier, on all three columns the retention factors of the first-eluting enantiomers, k1’,
were largest in the EtOH-containing mobile phase, which is illustrated for analyte 7 on
Crown 2 (Fig. 17).
As concerns the separation factors, no general trends could be observed:  was
larger for analytes 6a,6b and 6c,6d on Crown 1 in the MeOH, for 7a,7b and 7c,7d on
Crown 2 in the MeOH (Fig. 18) and for 8a,8b, 8c,8d, 9a,9b and 9c,9d on Crown 3 in the
IPA containing eluent systems. In most cases, RS was larger in the MeOH-containing
mobile phase.
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Table 8. Retention factors of the first-eluting enantiomer (k1’), separation factors (α),
resolutions (RS) and elution sequences of isoxazoline-fused cispentacin analogues in
MeOH-containing mobile phases
Compound Column Mobile phase(v/v) k1'  RS
Elution
sequence
6a, 6b Crown 1 90/10 0.20 1.20 0.25 b<a
5/95 1.84 1.12 0.75 b<a
Crown 2 90/10 0.03 1.00 0.00 -
5/95 1.76 1.11 0.25 b<a
6c,6d Crown 1 90/10 0.92 1.75 2.70 c<d
5/95 30.52 1.00 0.00 -
Crown 2 90/10 0.39 1.34 0.80 c<d
5/95 15.56 1.00 0.00 -
7a, 7b Crown 1 90/10 0.09 1.38 0.25 b<a
70/30 0.11 1.00 0.00 -
30/70 0.21 1.00 0.00 -
5/95 1.50 1.18 1.25 b<a
Crown 2 90/10 0.06 3.05 1.60 a<b
70/30 0.14 2.49 1.20 a<b
30/70 0.53 1.00 0.00 -
5/95 1.39 1.15 0.85 a<b
Crown 3 90/10 0.42 1.00 0.00 -
70/30 0.32 1.00 0.00 -
30/70 0.27 1.00 0.00 -
5/95 0.33 1.02 0.20 n.d.
7c, 7d Crown 1 90/10 0.54 1.00 0.00 -
70/30 0.85 1.00 0.00 -
30/70 3.72 1.07 0.25 c<d
5/95 18.28 1.10 0.45 c<d
Crown 2 90/10 0.42 1.26 0.55 c<d
70/30 0.66 1.26 0.75 c<d
30/70 1.96 1.06 0.45 c<d
5/95 10.47 1.00 0.00 -
Crown 3 90/10 0.88 1.30 1.55 c<d
70/30 0.63 1.35 1.30 c<d
30/70 1.02 1.31 0.95 c<d
5/95 1.48 1.26 0.20 c<d
8a, 8b Crown 1 90/10 0.07 1.20 0.30 a<b
5/95 3.58 1.24 1.20 a<b
Crown 2 90/10 0.08 1.00 0.00 -
5/95 2.73 1.11 1.25 b<a
Crown 3 90/10 0.23 1.71 1.50 b<a
5/95 0.42 1.00 0.00 -
8c, 8d Crown 1 90/10 0.08 1.00 0.00 -
5/95 1.84 1.37 0.60 d<c
Crown 2 90/10 0.05 1.00 0.00 -
5/95 1.25 1.31 0.80 d<c
Crown 3 90/10 0.46 1.00 0.00 -
5/95 0.50 1.00 0.00 -
9a, 9b Crown 1 90/10 0.16 1.00 0.00 -
5/95 3.20 1.25 1.60 a<b
Crown 2 90/10 0.20 1.00 0.00 -
5/95 2.34 1.23 1.70 b<a
9c, 9d Crown 1 90/10 0.08 1.00 0.00 -
5/95 1.31 1.46 0.80 d<c
Crown 2 90/10 0.05 1.00 0.00 -
5/95 0.88 1.44 0.85 d<c
Chromatographic conditions: columns, Crown 1, 2 and 3; mobile phase, H2O/MeOH (v/v)
+ 10 mM AcOH; temperature, ambient; flow rate, 0.5 mL min-1; detection, 210 nm
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Figure 17. Effects of the alcohol modifier on the chromatographic parameters for analyte
7. Chromatographic conditions: column, Crown 2; mobile phase, H2O/alcohol/AcOH =
90/10/10 (v/v/mM); temperature, ambient; flow rate, 0.5 mL min-1; detection, 210 nm
The effects of the alcohol (MeOH, EtOH or IPA) content of the mobile phase were
investigated on all three CSPs and the examples of analytes 7a,7b, and 7c,7d are depicted
in Table 8. In most cases, k’ increased with increasing alcohol content. This suggests that
the retention behaviour may be controlled by a HILIC mechanism at high alcohol contents.
Different extents of solvation of the stationary phase during HILIC and under the RP
conditions may explain the observed retention behaviour. However, in some cases, in the
MeOH-containing mobile phase for analytes 6a,6b, 6c,6d and 7a,7b on Crown 1 and for
all analytes on Crown 3, a U-shaped retention curve was observed. Similarly, a U-shaped
retention curve was obtained on Crown 3 in the EtOH-containing mobile phase for
analytes 8a,8b, 8c,8d, 9a,9b and 9c,9d. At higher water content, the retention factor
increased with increasing water content; this was probably due to enhanced hydrophobic
interactions between the analyte and the CSP in the water-rich mobile phases. When the
alcohol content of the mobile phase exceeded ~30-40%, the retention factor increased. This
suggests that the retention behaviour may be controlled by a HILIC interaction mechanism,
as mentioned above. The inflection points and the slopes of the U-shaped curves at higher
and lower alcohol concentrations differed somewhat for each compound. As regards the
variations in the separation factors () and resolutions (RS) with change of alcohol content,
no general trends were observed.
Interesting results were observed from comparisons of the retention behaviour of
the three crown ether-containing CSPs with the application of mobile phases containing
large or small amounts of water (Table 8). In the H2O/MeOH (v/v) + 10 mM AcOH eluent
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system, k1’ was larger on Crown 3 when the H2O content was larger, and on Crown 1
when the alcohol content was larger. In the former case, the most apolar Crown 3 in the
water-rich mobile phase favours the hydrophobic interactions between Crown 3 and the
analyte, resulting in larger k1’. In the latter case, the most polar Crown 1 in the alcohol-
rich eluent system favours the HILIC interactions, resulting in large k1’ values.
4.3.2. Effects of the nature and content of the acidic modifier
The effects of the nature and content of the acidic modifier on the separation were
investigated by the separation of analytes 8a,8b, 8c,8d, 9a,9b and 9c,9d in an aqueous
mobile phase at a constant concentration of the organic modifier. A comparison of the
chromatographic data obtained by using HCOOH, AcOH, TFA, HClO4, H2SO4 or H3PO4
as acidic modifier at a constant concentration of 10 mM in a hydro-organic mobile phase
containing MeOH, EtOH or IPA (70% v/v) demonstrated that in most cases larger k’ values
were obtained on the application of AcOH or HCOOH, while the other acids resulted in
lower k’ (upper part of Table 9); for analytes 8c,8d and 9c,9d, data are not shown, but
similar results were obtained).
H2SO4, HClO4, H3PO4 and TFA in the same concentration as AcOH resulted in
much lower levels of pH. As the pH was decreased, the ionic strength of the mobile phase
increased. The HILIC interaction of a protonated ionic analyte with the polar mobile phase
was then expected to increase, with a consequent decrease in the retention time. The ionic
strength can act as a shield with respect to host-guest complex formation, reducing the
retention when increased. As concerns the selectivity and resolution, in most cases larger 
and especially RS values were obtained when AcOH, HCOOH or in some cases (especially
with EtOH or IPA as mobile phase additive) H2SO4 was applied.
Increase of the AcOH or H2SO4 content in the aqueous mobile phase decreased the
retention factors, as shown in the bottom part of Table 9. As the acid content was elevated,
the ionic strength of the mobile phase increased, while the pHa decreased. As mentioned
above, the hydrophilic interaction of a protonated ionic analyte with the polar mobile phase
was then expected to increase, resulting in a decrease in the retention time.  and RS
exhibited different behaviour for analytes containing amino and carboxyl groups in cis
(a,b) or trans (c,d) positions. , for both types of analytes increased with increasing acid
content, while RS for analytes a,b increased and for analytes c,d decreased with increasing
acid concentration.
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Table 9. Chromatographic data, retention factors (k’), separation factors () and resolutions (RS) for analytes 8a,8b, 9a,9b and 9c,9d on (+)-(18-
crown-6)-2,3,11,12-tetracarboxylic acid CSP with variation of the type and concentration of the acidic modifier
Compound Nature of acid
Mobile phase: H2O/alcohol = 30/70 (v/v) + 10 mM acid
H2O/MeOH H2O/EtOH H2O/IPA
k1’  RS k1’  RS k1’  RS
8a,8b
HCOOH 0.69 1.26 0.85 1.03 1.20 0.55 1.53 1.17 0.45
AcOH 0.61 1.23 0.85 1.84 1.18 0.40 0.93 1.10 0.25
TFA 0.39 1.15 0.10 0.24 1.50 0.25 0.43 1.10 0.10
HClO4 0.31 1.13 0.10 0.53 1.10 0.10 0.71 1.13 0.10
H2SO4 0.36 1.24 0.20 0.50 1.35 0.75 0.96 1.21 1.10
H3PO4 0.54 1.26 0.65 0.59 1.26 0.65 0.72 1.20 0.45
9a,9b
HCOOH 0.65 1.33 1.00 1.09 1.20 0.65 1.35 1.21 0.80
AcOH 0.56 1.30 0.85 1.78 1.20 0.60 0.79 1.15 0.60
TFA 0.41 1.18 0.20 0.25 1.51 0.10 0.23 1.65 0.30
HClO4 0.32 1.37 0.10 0.52 1.17 0.10 0.75 1.06 0.10
H2SO4 0.36 1.39 0.20 0.50 1.45 1.40 0.83 1.30 1.30
H3PO4 0.57 1.26 0.50 0.57 1.34 0.65 0.64 1.29 0.60
Compound Concentrationof acid (mM)
Mobile phase
H2O/MeOH = 30/70 (v/v) + AcOH H2O/IPA = 30/70 (v/v) + H2SO4
9a,9b
0.5 1.64 1.10 0.20 1.06 1.21 0.75
1.0 1.56 1.11 0.15 0.66 1.29 0.85
5.0 1.11 1.23 0.65 0.51 1.44 0.90
10.0 0.56 1.30 0.85 0.40 1.51 0.95
20.0 0.58 1.28 0.90 0.37 1.55 1.05
30.0 0.93 1.25 0.95 0.31 1.61 1.25
9c,9d
0.5 0.46 1.35 1.00 0.39 1.57 1.10
1.0 0.39 1.51 0.95 0.26 1.71 1.00
5.0 0.37 1.53 0.80 0.09 2.53 0.95
10.0 0.20 1.87 0.75 0.05 3.59 0.90
20.0 0.08 2.85 0.65 0.05 3.55 0.85
30.0 0.02 4.00 0.20 0.07 3.97 0.75
Chromatographic conditions: column, Crown 1; mobile phase, H2O/alcohol = 30/70 (v/v) + acidic modifier; temperature, ambient; flow rate, 0.5 mL
min-1; detection, 205 nm
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4.3.3. Effect of the structures of the analytes on chiral recognition
The structures of the analytes influenced the chiral recognition. In the RP mode,
methyl or ethyl substitution exhibited a slight effect on the retention. On Crown 1 and 2, at
a given mobile phase composition, the methyl-substituted analogues interacted more
strongly with the selector than did the ethyl-substituted ones, resulting in larger retentions
(Table 8). However, on Crown 3, the interactions depended on the composition of the
mobile phase. In water-rich media, the ethyl-substituted analytes resulted in the larger
retention factors with the selector, wheres at higher MeOH contents, the methyl-substituted
ones did so. Through the steric interactions, the position of the methyl or ethyl group
influenced the  and RS values. Analytes 8a,8b were better separated than 6a,6b on all
CSPs, while analytes 6c,6d exhibited better separation efficiency than 8c,8d. In general,
9a-9d underwent better enantioseparation than 7a-7d.
For comparison of the performances of the three (+)-(18-crown-6)-2,3,11,12-
tetracarboxylic acid-based columns, separations were carried out with variation of the
mobile phase composition. In general, Crown 3 was more suitable in a water-rich mobile
phase, while Crown 1 and 2 exhibited better results in an alcohol-rich mobile phase
(Table 8). In conclusion, no one column is suited for the enantioseparation of all the
investigated unusual isoxazoline-fused 2-aminocyclopentanecarboxylic acids; they have a
highly complementary character.
4.3.4. Enantioseparation of four enantiomers of isoxazoline-fused cispentacin
stereoisomers
For the crown ether-based CSPs, separation of the diastereomers in one
chromatographic run was also attempted. The data listed in Table 10 reveal that separation
of the four stereoisomers could be achieved in most cases. Unfortunately, no
chromatographic condition was found for the baseline separation of 6a,6b and 6c,6d in one
chromatographic run.
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Table 10. Chromatographic data: retention factor, and resolution for the separation of four
enantiomers of isoxazoline-fused cispentacin derivatives on crown ether-containing
columns
Analyte Column MobilePhase k’1 k’2 k’3 k’4 RS1 RS2 RS3
Elution
sequence
6 Crown 1 a 0.20 0.26 0.93 1.67 0.20 3.72 3.39 b<a<c<d
7 Crown 2 b 0.32 1.14 2.76 4.17 1.73 2.66 1.61 a<b<c<d
8 Crown 1 c 2.01 2.86 11.40 12.99 1.92 13.68 1.72 d<c<a<b
9 Crown 1 c 2.34 3.35 9.99 11.11 2.16 12.92 2.11 d<c<a<b
Chromatographic conditions: mobile phase, a, H2O/MeOH = 90/10 (v/v) + 10 mM AcOH;b, H2O/EtOH = 50/50 (v/v) + 10 mM AcOH; c, H2O/MeOH = 5/95 (v/v) + 10 mM AcOH;
temperature, 5 °C for analytes 7, 8 and 9, 25 °C for analyte 6; flow rate, 0.5 mL min-1;
detection, 210 nm
4.4. Comparison of macrocyclic antibiotic- and crown ether-based CSPs
For the isoxazoline-fused 2-aminocyclopentanecarboxylic acid analogues, the
separation abilities of the two types of selectors can be compared. It is true for both types
of column that they have similar separation efficiencies for this type of analytes.
From a comparison of the retention factors, it seems that these analytes exhibited
stronger interactions with macrocyclic glycopeptide selectors. The retention factors were
generally higher, and in most cases were accompanied by higher resolution too.
These types of -amino acids probably prefer apolar stationary phases. The crown
ether-containing CSPs (Crown 1 and 2) are more polar (Crown 3 was an exception), than
the macrocyclic antibiotics and also have fewer chiral centres and active groups for
interactions. However, the strong inclusion complexation may contribute to the chiral
recognition and with thorough optimization (pH, the nature and concentration of the
alcohol and the acidic modifier, and temperature) the same or similar separation efficiency
can be attained on crown ether-based columns, too.
When both their advantages and disadvantages are taken into account, both types of
column are capable of the separation of these types of analytes.
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SUMMARY
In the course of this work, two types of -amino acid analogues, monoterpene-
based- and isoxasoline-fused 2-aminocyclopentanecarboxylic acids, were handled. The
chromatographic measurements were carried out on macrocyclic antibiotic-based and
crown ether-containing CSPs. Effects of the pH, the nature and the concentration of the
alcohol and acidic modifiers, and the temperature were investigated on the
chromatographic parameters.
Enantioseparation of monoterpene-based 2-aminocyclopentanecarboxylic acids on
macrocyclic antibiotic-based CSPs
RP, PO and PI experimental conditions were applied in this project. The CSPs used
were Chirobiotic T, T2, TAG, R, V and VAG columns.
The effects of the pH of the mobile phase were investigated. On the Chirobiotic T
column, increase of the pH of the mobile phase decreased the retention factors, while the
selectivity increased slightly and the resolution considerably.
As a result of the pH measurements the mobile phases contained 0.1% TEAA (pH
= 4.1) buffer and alcohol modifier. On the Chirobiotic T, T2 and TAG columns, with
increasing alcohol content the retentions changed according to U-shaped curves for all the
analytes (except for analyte 3 on the T and T2 columns). The explanation of this result was
that in water-rich eluents the hydrophobic interactions increased the k’ values, while in an
alcohol-rich mobile phase the HILIC interaction increased the retention. In the case of
analyte 3, the different behaviour could be attributed to the opposite positions of the amino
and carboxy groups. In general, the selectivity factors and resolutions neither described a
U-shaped curve nor increased with increasing alcohol content. The other three CSPs
(Chirobiotic R, V and VAG) did not give good results; the best resolution value was 1.00.
The elution sequence did not change during the measurements, except in the case of
analyte 2, where the elution sequence differed when the mobile phase was changed from
RP to PI mode.
The effects of temperature were also investigated on the T and TAG columns
between 10 and 40 °C and the thermodynamic parameters were determined in all cases. In
most cases, the enantioseparations were enthalpically-driven (the only exception was
analyte 3). Baseline resolution was achieved in all cases.
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Enantioseparation of isoxazoline-fused 2-aminocyclopentanecarboxylic acids on
macrocyclic antibiotic CSPs
With the application of MeOH as mobile phase additive, in most cases the retention
factors described a U-shaped curve. However, in the cases of 6a,6b on the T, T2 and TAG,
and of 7a,7b on the T and T2 columns, k’ increased with increasing MeOH content. For all
of the analytes, the Chirobiotic TAG column proved to be the most capables, the best
resolutions were achieved on it. For 8a,8b and 9a,9b, outstanding results were also
observed on the V and VAG columns. As concerns the elution sequence, it differed only
on the TAG CSP for the trans analogues.
The effects of temperature were investigated between 5 and 45 °C (in 10 °C
increments) on the Chirobiotic T and TAG CSPs. The thermodynamic parameters were
determined in all cases, and in one case the process of separation was entropically driven
(8a,8b on Chirobiotic TAG). On Chirobiotic T for analogues 6c,6d and 7c,7d, Tiso was 37
°C; the change in elution sequence with change of temperature for 6c,6d is illustrated in
Fig. 16.
As four pair of diastereomers exist for these types of analyte, the separation of four
diastereomers (eight enantiomers) was achieved. In the cases of 7a-7d and 8a-8d, the eight
enantiomers were separated in one chromatographic run, but the separation of 6a-6d and
9a-9d needed two chromatographic runs.
Enantioseparation of isoxazoline-fused 2-aminocyclopentanecarboxylic acids on crown
ether-containing CSPs
The effects of the alcohol (MeOH, EtOH or IPA) content of the mobile phase
showed that in most cases k’ increased with increasing alcohol content. This suggests that
the retention behaviour may be controlled by a HILIC mechanism at high alcohol contents.
In some cases, however, in MeOH-containing mobile phases on Crown 1 and for all
analytes on Crown 3, a U-shaped retention curve was observed. At higher water content,
the retention factor increased with increasing water content; this was probably due to
enhanced hydrophobic interactions between the analyte and the CSP in the water-rich
mobile phases.
Comparison of the retention behaviour of the three crown ether-containing CSPs
with the application of mobile phases containing large or small amounts of water revealed
that k1’ was larger on Crown 3 when the H2O content was larger and on Crown 1 when
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the alcohol content was larger. In the former case, the most apolar Crown 3 in a water-rich
mobile phase favours the hydrophobic interactions between Crown 3 and the analyte,
resulting in larger k1’. In the latter case, the most polar Crown 1 in an alcohol-rich eluent
system favours the HILIC interactions, resulting in large k1’ values.
A comparison of the chromatographic data obtained by using HCOOH, AcOH,
TFA, HClO4, H2SO4 or H3PO4 as acidic modifier demonstrated that in most cases larger k’
values were obtained on the application of AcOH or HCOOH, while the other acids
resulted in lower k’. Better selectivity and resolution were obtained when AcOH and
HCOOH, and in some cases H2SO4 (with EtOH or IPA) were used. As concerns the effects
of the concentration of the acid modifier, increase of the AcOH or H2SO4 content
decreased the k’ values.  increased with increasing acid concentration, whereas the RS
values decreased with increasing concentration for the trans analogues, and increased for
the cis analogues.
The structures of the analytes also influenced the chiral recognition. On all CSPs,
the values of selectivity and resolution were better for analytes 8a,8b and 9a,9b than for
6a,6b and 7a,7b; the position of substituent R influenced the chromatographic parameters.
The trans analogues exhibited different chromatographic behaviour.
The elution sequence was determined in all cases, but no general rule could be
found to describe the elution behaviour of these compounds.
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IAPPENDIX
The IUPAC names of monoterpene-based -amino acids (Fig. 11)
(1R,2R,3S,5R)-2-Amino-6,6-dimethylbicyclo[3.1.1]heptane-3-carboxylic acid (1a), (1S,2S,3R,5S)-
2-amino-6,6-dimethylbicyclo[3.1.1]heptane-3-carboxylic acid (1b), (1R,2R,3R,5R)- 2-amino-6,6-
dimethylbicyclo[3.1.1]heptane-3-carboxylic acid (2a), (1S,2S,3S,5S)-2-amino-6,6-
dimethylbicyclo[3.1.1]heptane-3-carboxylic acid (2b), (1S,2S,3S,5R)-3-amino-6,6-
dimethylbicyclo[3.1.1]heptane-2-carboxylic acid (3a), (1R,2R,3R,5S)-3-amino-6,6-
dimethylbicyclo[3.1.1]heptane-2-carboxylic acid (3b), (1R,2R,3S,5R)-2-aminopinane-3-carboxylic
acid (4a), (1S,2S,3R,5S)-2-aminopinane-3-carboxylic acid (4b), (1S,2S,3R,4S,5S)-2-amino-4,6,6-
trimethylbicyclo[3.1.1]heptane-3-carboxylic acid (5a), and (1R,2R,3S,4R,5R)-2-amino-4,6,6-
trimethylbicyclo[3.1.1]heptane-3-carboxylic acid (5b).
The IUPAC names of isoxazoline-fused 2-aminocyclopentanecarboxylic acid
analogues (Fig. 12)
(3aS,4R,5S,6aS)-4-amino-3-methyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic
acid (6a), (3aR,4S,5R,6aR)-4-amino-3-methyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-
carboxylic acid (6b), (3aS,4R,5R,6aS)-4-amino-3-methyl-4,5,6,6a-tetrahydro-3aH-
cyclopenta[d]isoxazole-5-carboxylic acid (6c), (3aR,4S,5S,6aR)-4-amino-3-methyl-4,5,6,6a-
tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (6d), (3aS,4R,5S,6aS)-4-amino-3-ethyl-
4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (7a), (3aR,4S,5R,6aR)-4-amino-
3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (7b), (3aS,4R,5R,6aS)-4-
amino-3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (7c),
(3aR,4S,5S,6aR)-4-amino-3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic
acid (7d), (3aR,5S,6S,6aS)-6-amino-3-methyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-
carboxylic acid (8a), (3aS,5R,6R,6aR)-6-amino-3-methyl-4,5,6,6a-tetra-hydro-3aH-
cyclopenta[d]isoxazole-5-carboxylic acid (8b), (3aR,5S,6R,6aS)-6-amino-3-methyl-4,5,6,6a-
tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (8c), (3aS,5R,6S,6aR)-6-amino-3-methyl-
4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (8d), (3aR,5S,6S,6aS)-6-amino-
3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (9a), (3aS,5R,6R,6aR)-6-
amino-3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic acid (9b),
(3aR,5S,6R,6aS)-6-amino-3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-carboxylic
acid (9c), and (3aS,5R,6S,6aR)-6-amino-3-ethyl-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-5-
carboxylic acid (9d).
II
Selected chromatograms of monoterpene-based -amino acids
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Chromatographic conditions: column, Chirobiotic T (analytes 1 and 3), Chirobiotic T2 (analyte 2)
and Chirobiotic TAG (analytes 4 and 5); mobile phase, 0.1% TEAA (pH = 4.1)/MeOH = 10/90
(v/v) (analyte 1,3 and 5), 0.1% TEAA (pH = 4.1)/MeOH = 40/60 (v/v) (analyte 4), 0.1% TEAA (pH
= 4.1)/MeOH = 98/2 (v/v) (analyte 2); temperature, 25 °C (analytes 1-4), 20 °C (analyte 5); flow
rate, 0.5 mL min-1; detection, 210 nm.
III
Selected chromatograms of isoxazoline-fused -amino acids on macrocyclic
antibiotics
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MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v) (analyte 9); temperature, 25 °C (analytes 6 and 7), 10 °C
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IV
Selected chromatograms of isoxazoline-fused -amino acids on crown
ether-based CSPs
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Chromatographic conditions: column, Crown 1 (for all analytes); mobile phase,
H2O/MeOH/AcOH = 90/10/10 (v/v/mM) (analyte 6), H2O/EtOH/AcOH = 50/50/10 (v/v/mM)
(analyte 7), H2O/MeOH/AcOH = 5/95/10 (v/v/mM) (analytes 8 and 9); temperature, 25 °C(analyte 6), 5 °C (analytes 7 and 9); flow rate, 0.5 mL min-1; detection, 210 nm.
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a b s t r a c t
The enantiomers of ﬁve monoterpene-based 2-amino carboxylic acids were directly separated on chiral
stationary phases containing macrocyclic glycopeptide antibiotics such as teicoplanin (Astec Chirobiotic
T and T2) and teicoplanin aglycone (Chirobiotic TAG) as chiral selectors. The effects of pH, the mobile
phase composition, the structure of the analyte and temperature on the separations were investigated.
Experiments were performed at constant mobile phase compositions in the temperature range 10–40 ◦C
to study the effects of temperature and thermodynamic parameters on separations. Apparent thermody-
namic parameters and Tiso values were calculated from plots of ln k or ln˛ versus 1/T. Some mechanistic
aspects of the chiral recognition process are discussed with respect to the structures of the analytes. It
was found that the enantioseparations were in most cases enthalpy driven. The sequence of elution of
the enantiomers was determined in all cases.
© 2010 Elsevier B.V. All rights reserved.
1. Introduction
-Amino acids are key building blocks of numerous bioac-
tive molecules [1–4]. Icofungipen (PLD-118; (1R,2S)-2-amino-4-
methylenecyclopentanecarboxylic acid), a-aminoacid, upsets the
biosynthesis of protein in Candida albicans [5]. -Amino acids and
their foldameric oligomers are currently at the focus of research
interest [6,7].
Enantiomerically pure -pinene, -pinene and 3-carene can be
transformed into -amino acid derivatives [8,9,10,11], which are
excellent building blocks for the syntheses of monoterpene-fused
saturated 1,3-heterocycles [9,12]. Also, theywere used successfully
as chiral auxiliaries in the enantioselective reactions of Et2Zn with
aromatic aldehydes [10,12,8,9]. Apopinane-based -amino acids
were used as building blocks in the construction of stable H12
foldameric helices and in Ugi four-centre three-component reac-
tions [11,13,14]. The latternew familyofmonoterpene-based chiral
-lactams and -amino acid derivatives derived from (−)- and
(+)-apopinene recently were reported to eliminate the disadvan-
∗ Corresponding author. Tel.: +36 62 544000/3656; fax: +36 62 420505.
E-mail address: apeter@chem.u-szeged.hu (A. Péter).
tageous steric effect of the methyl substituent on the pinane ring
system [11]. The regioisomeric trans apopinane-based -amino
acids could be prepared by conjugate addition of lithium amides
to (−)- and (+)-tert-butyl myrtenate, derived from natural (−)-
myrtenal and (+)--pinene [3].
The wide-ranging utility of these compounds requires ana-
lytical methods to check on the stereochemistry of the ﬁnal
product. One of the most frequently applied techniques is
chiral high-performance liquid chromatography (HPLC). HPLC
enantioseparations of -amino acids have been performed by
both indirect and direct methods. In the past decade, chi-
ral derivatizing agents (CDAs) such as Marfey’ reagent (FDAA),
2,3,4,6-tetra-O-acetyl--d-glucopyranosyl isothiocyanate (GITC),
N-(4-nitrophenoxycarbonyl)-phenylalanine methoxyethyl ester
[(S)-NIFE] [15], chiral stationary phases (CSPs) such as macrocyclic
glycopeptides [16,17], quinine derived [18], crown ether based
[19,20], rapid double derivatization techniquewith gas chromatog-
raphy [21] and (18-crown-6)-2,3,11,12-tetracarboxylic acid as a
chiral NMR solvating agent have been used for the enantiosepa-
ration of -amino acids [22].
In all chromatographic modes, the selectivity and retention fac-
tors are mainly controlled by the concentration and nature of the
mobile phase components, together with other variables, such as
0021-9673/$ – see front matter © 2010 Elsevier B.V. All rights reserved.
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the pHof themobile phase. Enantioselective retentionmechanisms
are often inﬂuenced by temperature. This has been noted for some
time in chiral gas chromatography [23,24]. It additionally known
that there are both achiral and chiral contributions to retention that
can vary with a wide variety of experimental parameters [24–28].
Several papers have been published that discuss the effects of tem-
perature on enantiomers HPLC separation [29–33].
The dependence of the retention of an analyte on temperature
can be expressed by the van’t Hoff equation, which may be inter-
preted in terms certain ofmechanistic aspects of chiral recognition:
ln k = −H
◦
RT
+ S
◦
R
+ ln  (1)
in which k is retention factor, H◦ is the enthalpy of transfer of
the solute from the mobile phase to the stationary phase, S◦ is
the entropy of transfer of the solute from the mobile phase to the
stationary phase, R is the gas constant, T is the temperature and
 is the phase ratio of the column. This equation reveals that a
plot of ln k versus 1/T is linear, with slope −H◦/R and intercept
S◦/R+ ln, if H◦ is invariant with temperature. Since the value
of  is often not known, the S◦* values [S◦* =S◦ +R ln] calcu-
lated from the intercepts of the plots via Eq. (1) are generally used.
Any uncertainty in the phase ratio affects all S◦* values in the
same manner. In chiral chromatography, however, the van’t Hoff
plotsoftendeviate fromlinearity, possiblyasa result of the inhomo-
geneity of the CSP surface, leading to amixed retentionmechanism
[31,32].
The corresponding(H◦) and(S◦) values for the separated
enantiomers can be determined from a modiﬁcation of Eq. (1):
ln ˛ = −(H
◦)
RT
+ (S
◦)
R
(2)
where ˛ is the selectivity factor (˛= k2/k1).
In the present paper, direct HPLC methods are described for
the enantioseparation of monoterpene-based 2-amino carboxylic
acids, with the application of different macrocyclic glycopeptide-
based CSPs. For comparison purposes,most of the separationswere
carried out at constant mobile phase compositions at different
temperatures. The effects of pH, the mobile phase composition,
the speciﬁc structural features of the analytes and selectors and
temperature on the retention are discussed on the basis of the
experimental data. The elution sequence was determined in all
cases.
2. Experimental
2.1. Materials and methods
Theenantiomers ofmonoterpene-based cis--aminoacidswere
prepared in two steps by literature methods [10,11,8]. Chlorosul-
fonyl isocyanate addition to the corresponding chiralmonoterpene
((−)-apopinene for 1A and 2A, (+)-apopinene for 1B and 2B, (−)-
-pinene for 4A, (+)--pinene for 4B, (−)--pinene for 5A, and
(+)--pinene for 5B) afforded -lactams in highly regio- and stere-
ospeciﬁc reactions, subsequent acidic hydrolysis resulted in the
corresponding cis--aminoacids. Thebase-catalysed isomerization
of the esters of the cis-amino acids derived from apopinene (1A
and 1B), followed by hydrolysis, afforded the corresponding trans
enantiomers 2A and 2B in excellent yields [11]. The regioisomeric
trans apopinane-based-amino acids 3A and 3B could be prepared
by conjugate addition of lithium amides to (−)- and (+)-tert-butyl
myrtenate, derived respectively from natural (−)-myrtenal and
(+)--pinene, followed by catalytic debenzylation and hydrolysis
[3].
Methanol (MeOH) of HPLC grade was purchased from Scharlau
(Sentmenat, Spain). Triethylamine (TEA), glacial acetic acid (AcOH),
triethylammonium-acetate (TEAA), ethanol (EtOH), n-propanol
(PrOH), 2-propanol (IPA) and other reagents of analytical reagent
grade were from Sigma–Aldrich (St. Louis, MO, USA). The Milli-Q
water was further puriﬁed by ﬁltration on a 0.45-m ﬁlter, type
HV, Millipore (Molsheim, France).
All the compounds mentioned in Fig. 1 were evaluated with dif-
ferent mobile phases. Reversed-phase mobile phases consisted of
0.1% TEAA (pH 4.1)/MeOH=98/2, 90/10, 80/20, 60/40, 40/60, 20/80
and 10/90 (v/v), 100% MeOH while polar ionic mobile phase was
MeOH/AcOH/TEA=100/0.1/0.1 (v/v/v).
2.2. Apparatus
TheHPLC separationswere carried out on aWatersHPLC system
consisting of an M-600 low-pressure gradient pump, an M-2996
photodiode-array detector and a Millenium32 Chromatography
Manager data system (Waters Chromatography, Milford, MA, USA)
equipped with a Rheodyne Model 7125 injector (Cotati, CA, USA)
with a 20-L loop.
The macrocyclic glycopeptide-based stationary phases used for
analytical separationwere teicoplanin-containingChirobioticTand
T2 and teicoplanin aglycone-containing Chirobiotic TAG columns,
250mm×4.6mm I.D., 5-m particle size (for each column) (Astec,
Whippany,NJ,USA). Chirobiotic T andT2arebothbasedon silica gel
with a 5-mparticle size, but the Chirobiotic Tmaterial has a 120 A˚
pore size and the Chirobiotic T2 material a 200 A˚ pore size. More-
over, the linkage chain in Chirobiotic T2 is approximately twice as
long as that in Chirobiotic T. Hence, the coverage and spacing will
be different for the two. This is manifested in the form of steric and
non-enantioselective hydrophobic interactiondifferences between
the two columns.
The columnswere thermostated in a SparkMistral column ther-
mostat (Spark Holland, Emmen, The Netherlands). The precision of
temperature adjustment was ±0.1 ◦C.
3. Results and discussion
The experimental conditions, including the pH of the mobile
phase, the buffer type, the concentration of the organic modiﬁer
and the temperature, were investigated. The analytes in this study
(Fig. 1)possess amonoterpene-basedskeleton.Besides carboxyand
primary amino groups (in exo or endo position), analogues 4 and 5
bear onemethyl group, in position 2 or 4. These differences result in
different steric effects and inﬂuence the hydrophobicity, bulkiness
and rigidity of the molecules, depending on how their atoms are
linked and how capable they are of different interactions with the
selector.
The effects of pH on the separation were investigated in
the acidic pH range. A decrease in the pH of the 0.1% aqueous
TEAA/MeOH=60/40 (v/v) eluent system from 6.50 to 4.00 con-
siderably increased the retention factors of analyte 4 on both the
Chirobiotic T and TAG columns; the selectivity decreased slightly,
while the resolution did so considerably. Similar results were
obtained by Armstrong et al. [34] on a teicoplanin CSP for analytes
with free carboxylic acid groups. The pH 6–7 that produced the
highest ˛ also yielded the best resolution. According to the Arm-
strong’s work [34] the protonation of teicoplanin either directly
affects the coulombic or dipolar interactions between the analyte
and the CSP, or indirectly inﬂuences the separation by changing the
conformation of the selector.
All data relating to the separation of the compounds, including
the retention factors, separation factors and resolutions for each
analyte on the three different Chirobiotic columns, are given in
Table 1 . For purposes of comparison and to simplify the presenta-
tion, Table 1 lists only the chromatographic results obtained when
the enantiomeric separationwas achievedwithmobile phase com-
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1a 1R2R3S5R 
 
1b 1S2S3R5S 
 
2a 1R2R3R5R 
 
2b 1S2S3S5S 
 
 
3a 1S2S3S5R 
 
3b 1R2R3R5S 
 
4a 1R2R3S5R 
 
4b 1S2S3R5S 
5a 1S2S3R4S5S 
 
5b 1R2R3S4R5R 
Fig. 1. Chemical structures of analytes. 1a (1R,2R,3S,5R)-2-amino-6,6-dimethylbicyclo[3.1.1]heptane-3-carboxylic acid; 1b (1S,2S,3R,5S)-2-amino-6, 6-
dimethylbicyclo[3.1.1]heptane-3-carboxylic acid; 2a (1R,2R,3R,5R)-2-amino-6,6-dimethylbicyclo[3.1.1]heptane-3-carboxylic acid; 2b (1S,2S,3S,5S)-2-amino-6,6-dimethyl-
bicyclo[3.1.1]heptane-3-carboxylic acid; 3a (1S,2S,3S,5R)-3-amino-6,6-dimethylbicyclo[3.1.1]heptane-2-carboxylic acid; 3b (1R,2R,3R,5S)-3-amino-6,6-
dimethylbicyclo[3.1.1]heptane-2-carboxylic acid; 4a (1R,2R,3S,5R)-2-aminopinane-3-carboxylic acid; 4b (1S,2S,3R,5S)-2-aminopinane-3-carboxylic acid; 5a
(1S,2S,3R,4S,5S)-2-amino-4,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxylic acid; 5b (1R,2R,3S,4R,5R)-2-amino-4,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxylic acid.
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Fig. 2. Selected chromatograms for analytes 1a,b–5a,b and 1b, 2a–4a and 5b chromatographic conditions: column, Chirobiotic T for analytes 1 and 3, Chirobiotic T2 for
analytes 2 and Chirobiotic TAG for analytes 4 and 5; mobile phase, 0.1% TEAA (pH 4.1)/MeOH=10/90 (v/v) for analytes 1, 3 and 5, 0.1% TEAA (pH 4.1)/MeOH=40/60 (v/v) for
4 and 0.1% TEAA (pH 4.1)/MeOH=98/2 (v/v) for 2; temperature, ambient for analytes 1–4, 20 ◦C for 5; ﬂow rate, 0.5mLmin−1; detection, 210nm.
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Table 1
Chromatographic data, retention factor of ﬁrst eluted enantiomer (k1 ′), separation factor (), resolution (RS) and conﬁguration of the ﬁrst eluted enantiomer of monoterpene-
based 2-amino acids on different monocyclic glycopeptide-based columns.
Analyte Column Mobile phase TEAA/MeOH (v/v),
a MeOH/AcOH/TEA (v/v/v), b
k1 ′ ˛ RS Conﬁguration of the
ﬁrst eluted enantiomer
1
T 90/10, a 3.48 1.14 1.27 1R2R3S5R
40/60, a 1.98 1.08 0.72
10/90, a 2.65 1.15 1.74
0/100, a 4.18 1.19 1.85
100/0.1/0.1, b 3.05 1.24 1.57
T2 90/10, a 3.21 1.00 0.00
40/60, a 1.59 1.12 1.24
10/90, a 2.00 1.16 1.40
0/100, a 2.67 1.19 1.17
100/0.1/0.1, b 2.01 1.00 0.00
TAG 90/10, a 6.92 1.00 0.00
40/60, a 3.74 1.15 1.79
10/90, a 4.89 1.22 1.63
0/100, a 6.61 1.23 1.13
100/0.1/0.1, b 3.88 1.00 0.00
2
T 90/10, a 3.28 1.00 0.00 1R2R3R5R
40/60, a 2.30 1.04 0.39
10/90, a 3.65 1.06 0.80
0/100, a 4.73 1.08 0.90
100/0.1/0.1, b 3.39 1.08 0.56 1S2S3S5S
T2 90/10, a 3.13 1.18 1.35 1R2R3R5R
40/60, a 2.23 1.03 0.27
10/90, a 3.35 1.05 0.51
0/100, a 5.98 1.06 0.60
100/0.1/0.1, b 2.32 1.09 0.42 1S2S3S5S
TAG 90/10, a 7.63 1.19 1.06 1R2R3R5R
40/60, a 4.88 1.00 0.00
10/90, a 7.05 1.00 0.00
0/100, a 8.96 1.02 1.53
100/0.1/0.1, b 4.09 1.00 0.00 1S2S3S5S
3
T 90/10, a 11.95 1.00 0.00 1R2R3R5S
40/60, a 7.49 1.00 0.00
10/90, a 3.68 1.15 1.34
0/100, a 1.30 1.48 3.49
100/0.1/0.1, b 3.17 1.32 2.67
T2 90/10, a 10.11 1.00 0.00
40/60, a 2.43 1.12 0.62
10/90, a 2.00 1.22 1.22
0/100, a 1.80 1.29 1.97
100/0.1/0.1, b 2.84 1.09 0.95
TAG 90/10, a 11.90 1.07 0.81
40/60, a 5.96 1.08 0.35
10/90, a 4.75 1.29 1.83
0/100, a 4.84 1.32 2.76
100/0.1/0.1, b 3.13 1.35 1.97
4
T 90/10, a 3.28 1.34 2.95 1S2S3R5S
40/60, a 1.79 1.08 0.66
10/90, a 2.17 1.15 1.32
0/100, a 3.29 1.22 1.38
100/0.1/0.1, b 2.07 1.30 2.31
T2 90/10, a 3.22 1.20 1.78
40/60, a 1.40 1.12 1.07
10/90, a 1.52 1.27 1.78
0/100, a 1.90 1.45 1.92
100/0.1/0.1, b 1.25 1.65 2.11
TAG 90/10, a 9.68 1.06 0.48
40/60, a 3.86 1.17 1.68
10/90, a 3.25 1.25 1.80
0/100, a 4.63 1.30 1.83
100/0.1/0.1, b 2.69 1.49 3.27
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Table 1 (Continued )
Analyte Column Mobile phase TEAA/MeOH (v/v),
a MeOH/AcOH/TEA (v/v/v), b
k1 ′ ˛ RS Conﬁguration of the
ﬁrst eluted enantiomer
5
T 90/10, a 4.40 1.00 0.00 1R2R3S4R5R
40/60, a 1.91 1.00 0.00
10/90, a 2.44 1.05 0.67
0/100, a 3.69 1.09 0.81
100/0.1/0.1, b 2.51 1.12 1.78
T2 90/10, a 4.38 1.12 0.89
40/60, a 1.59 1.08 0.74
10/90, a 1.90 1.10 0.86
0/100, a 2.24 1.14 0.90
100/0.1/0.1, b 1.54 1.17 0.75
TAG 90/10, a 10.93 1.07 0.66
40/60, a 4.49 1.09 0.81
10/90, a 3.86 1.11 1.09
0/100, a 5.34 1.16 1.11
100/0.1/0.1, b 2.88 1.25 1.36
Chromatographic conditions: columns, T, Chirobiotic T, T2, Chirobiotic T2, TAG, Chirobiotic TAG; mobile phase, a, 0.1% TEAA (pH 4.1)/MeOH (v/v), b, MeOH/AcOH/TEA (v/v/v);
ﬂow rate, 0.5mL min−1; detection, 210nm.
positions of 0.1% TEAA (pH 4.1)/MeOH=90/10, 40/60 and 10/90
(v/v), 100% MeOH and MeOH/AcOH/TEA=100/0.1/0.1 (v/v/v). At a
given mobile phase composition, the retention factors were lower
on the teicoplanin CSPs (T and T2) than on the aglycone CSP (TAG)
(except for analyte 3 in some cases). The native teicoplanin phase
(Chirobiotic T) exhibited intermediate k′ values. Similar trends,
with higher k′ values on Chirobiotic TAG than on a Chirobiotic T
column, were observed by Berthod et al. [35], D’Acquarica et al.
[16] and Péter et al. [36–38] for unusual -amino acids and cyclic
-amino acids. Comparison of the data for the Chirobiotic T and
T2 columns revealed that the retention factors on Chirobiotic T
were somewhat larger (except for analytes 2 and 3 at 100% MeOH)
(Table 1). Slightly higher k′ values on Chirobiotic T2 than on Chi-
robiotic T were observed by Péter et al. [38] for 3-homoamino
acids.
The effects of the MeOH content of the mobile phase were
investigated on all three CSPs. In most cases, a U-shaped reten-
tion curve was observed for all analogues (the only exception was
analyte 3). At higher water contents, the retention factor increased
with increasing water content; this was probably due to enhanced
hydrophobic interactions between the analyte and the CSP in the
water-rich mobile phases (Table 1). In the reversed-phase mode,
one of the most important interactions between the analyte and
the CSP is the hydrophobic interaction inside the “basket” of the
glycopeptide. Here, an increase in k′ at high water content was
observed for all analytes (Table 1). When the MeOH content of the
mobile phase exceeded ∼50%, the retention factor increased (an
exception was analyte 3). This suggests that the separation may
rather be controlled by the hydrophilic interaction chromatogra-
phy (HILIC) than by the reversed-phase mechanism at high MeOH
contents. In this study, as earlier [34], the inﬂection point and the
slope of the U-shaped curve at higher and lower MeOH concen-
trations differed somewhat for each compound. Different extents
of solvation of the stationary phase during HILIC and under the
reversed-phase conditions may explain the observed retention
behaviour. For analyte 3, an increase in k′ was observed with
increasing water content. The different behaviour of analyte 3 may
be due to the different positions of the carboxy and amino groups,
resulting in differences in the steric interaction with the selector.
In regard to the variations in the separation factors (˛) and reso-
lutions (RS) with change of the MeOH content, no general trends
were observed.
Use of the MeOH/AcOH/TEA=100/0.1/0.1 (v/v/v) mobile phase
systemgenerally resulted in lower retention thanwith 100%MeOH
(except for analyte 3). However, for analytes 4 and 5, in most cases
despite the lower k′ values, higher ˛ and RS values were obtained,
indicating that the level of chiral discrimination improved in the
polar ionic mode probably due to the steric effect of methyl group
(Table 1).
The structures of the analytes inﬂuenced the chiral recognition.
In the reversed-phase mode in water-rich mobile phases, analyte
3 exhibited large k1 ′ values, not accompanied by high resolution.
At high water contents, the non-speciﬁc hydrophobic interaction
resulted in high retention without chiral recognition. The value of
˛ reached its maximum when using mobile phases of high MeOH
content. Analytes 4 and 5, which have an additional methyl group,
are sterically constrained. In most cases this led to higher ˛ (and
RS) values relative to those for analytes 1 and 2. Interestingly, the
position of the methyl group on the cycloalkane skeleton (position
2 or 4) inﬂuenced the values of ˛ and RS considerably; in that the
more constrained analyte 4 displayed higher ˛ and RS values than
those of analyte 5.
Elution sequencesweredetermined in all cases. For analytes1–5
on the Chirobiotic T, T2 and TAG columns, no consistent elution
sequence was observed. Neither the conﬁguration of the carbon
atom attached to the carboxyl group nor that of the carbon atom
attached to the amino group determined the elution sequence,
and in the case of analyte 2 the elution sequence differed when
the mobile phase was changed from reversed-phase to polar ionic
mode. Selected chromatograms for analytes 1–5 are depicted in
Fig. 2.
3.1. Effects of temperature and thermodynamic parameters
In order to investigate the effects of temperature on the chro-
matographic parameters, a variable-temperature studywas carried
out on Chirobiotic T and TAG columns over the temperature range
10–40 ◦C (in 5 or 10 ◦C increments). Experimental data for the
mobile phase 0.1% TEAA (pH 4.1)/MeOH=10/90 (v/v) are listed in
Table 2. A comparison of the retention factors in Table 2 and Fig. 3
reveals that all of the recorded values decreased with increasing
temperature (similar tendencies were measured at other mobile
phase compositions). It is evident that an increase in the separation
temperature lowers the separation factor, ˛. However, for analyte
3 on the Chirobiotic T column, ˛ (and RS) increased with increas-
ing temperature (Fig. 3). Increasing temperature may improve the
peak symmetry and efﬁciency, and therefore the resolution may
also improve.
Since the effect of temperature on the separation was complex,
an extensive study relating to the thermodynamics of this system
was carried out. The initial step of this process is to accumulate
accurate chromatographic data from which van’t Hoff plots were
constructed [Eq. (1)]. The H◦ and S◦* values calculated from the
slopes and intercepts of these plots for the enantiomers on all three
L. Sipos et al. / J. Chromatogr. A 1217 (2010) 6956–6963 6961
Table 2
Retention factor of ﬁrst-eluting enantiomer (k′), separation factor (˛) and resolution (RS) of enantiomers of monoterpene-based 2-amino carboxylic acids 1–5 as a function
of temperature.
Analyte Columns k1 ′ , , RS Temperature (◦C)
10 15 20 30 40
1 T k1 ′ 4.49 4.18 4.05 3.58 3.21
 1.13 1.12 1.12 1.11 1.10
RS 1.66 1.64 1.51 1.59 1.62
TAG k1 ′ 6.79 6.29 5.81 5.09 4.63
 1.17 1.16 1.15 1.14 1.12
RS 1.46 1.48 1.66 1.71 1.88
2 T k1 ′ 5.84 5.54 5.31 4.97 4.63
 1.04 1.03 1.03 1.02 1.01
RS 0.53 0.50 0.39 0.38 0.46
TAG k1 ′ 10.66 9.96 9.65 8.68 8.12
 1.00 1.00 1.00 1.00 1.00
RS 0.00 0.00 0.00 0.00 0.00
3 T k1 ′ 7.30 6.26 5.66 4.76 4.05
 1.09 1.11 1.12 1.14 1.17
RS 0.70 0.81 0.85 1.07 1.09
TAG k1 ′ 13.37 10.21 8.09 6.18 4.08
 1.20 1.17 1.13 1.09 1.04
RS 1.97 1.33 1.04 0.75 0.33
4 T k1 ′ 3.74 3.51 3.35 3.06 2.73
 1.13 1.12 1.11 1.10 1.09
RS 1.27 1.28 1.30 1.32 1.35
TAG k1 ′ 5.18 4.86 4.48 4.13 3.75
 1.20 1.19 1.18 1.17 1.16
RS 1.47 1.74 1.84 1.95 2.09
5 T k1 ′ 4.29 4.02 3.77 3.43 3.08
 1.05 1.05 1.04 1.04 1.03
RS 0.72 0.67 0.61 0.48 0.38
TAG k1 ′ 6.23 5.82 5.64 4.89 4.37
 1.12 1.11 1.10 1.09 1.07
RS 1.24 1.25 1.30 1.29 1.22
Chromatographic conditions: column, T, Chirobiotic T, TAG, Chirobiotic TAG;mobile phase, 0.1% TEAA (pH4.1)/MeOH=10/90 (v/v); ﬂow rate, 0.5mlmin−1; detection, 210nm.
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columns were negative (Table 3). The second-eluting enantiomers
have more negative S◦* values, it is likely that they have fewer
degrees of freedom on the CSP, i.e., they are held at more points
or are less able to move or rotate. It is widely accepted that both
enantiomers undergo the same non-speciﬁc interactions, whereas
the more strongly retained one is subject to additional stereospe-
ciﬁc interactions. Moreover, it was observed that H◦1 and H◦2,
and in parallel S◦∗1 and S
◦∗
2, for the Chirobiotic T column were in
most cases less negative than those for the Chirobiotic TAG column.
This may be due to the fact that the teicoplanin aglycone (TAG) has
been the sugar units removed and thismaypromote the interaction
between the analyte and the CSP.
Of the ﬁve analytes, analyte 2 exhibited the smallest, and ana-
lyte 3 the largest −H◦ and −S◦* values. The positions (2 and
3) of the amino and carboxy groups and their trans conﬁguration
in 2 probably inhibit ﬁtting and orientation in the cavity (the sugar
moieties on Chirobiotic T improved the chiral recognition, while on
teicoplanin aglycone no separation was observed), and the separa-
tion was thermodynamically less favorable. The largest −H◦ and
−S◦* values for 3 indicate that, despite the trans conﬁguration,
the separation sterically was favorable.
The differences in the changes in enthalpy and entropy, (H◦)
and (S◦), are also presented in Table 3. The −(H◦) values
ranged from −1.5 to 3.3 kJmol−1. The interactions of 3 with the
Chirobiotic TAG stationary phasewere characterized by the highest
negative (H◦) value, while analyte 3 on Chirobiotic T exhibited
a positive (H◦). The trends in the change in −(S◦) showed
that analyte 3 on Chirobiotic TAG displayed the largest negative
entropies,−(S◦) ranging from−6.1 to 10.2 Jmol−1 K−1 (Table 3).
For analyte 3, similarly to (H◦) on Chirobiotic T column (S◦)
was also positive. The (S◦) values are controlled by the dif-
ference in the degrees of freedom between the stereoisomers on
the CSP, and mainly by the number of solvent molecules released
from both the chiral selector and the analyte when the analyte is
associated with the CSP.
The thermodynamic parameter −(G◦) suggests that
teicoplanin without sugar units induces highly efﬁcient binding to
the selector, as reﬂected by the large negative (G◦) values for 1,
3, 4 and 5. For analyte 2 on Chirobiotic T (G◦) exhibits a small
negative value while on Chirobiotic TAG, the enantiomers of ana-
lyte 2 were not separable at this eluent composition. For analytes
1–5 on both columns (with exception of analyte 3 on Chirobiotic T)
the selector–selectand complex formation proceeds via multiple
intermolecular interactions and was generally exothermic, with a
corresponding negative entropic contribution.
For analyte 3, on Chirobiotic T, the positive (S◦) compen-
sated for the positive (H◦) and resulted in a relatively high
−(G◦) value. The teicoplanin,which contains several sugarmoi-
eties having more chiral centres, ensures more interaction sites for
the analytes, leading tomorenegative−(G◦) values. In this tem-
perature range, enantioresolution is entropically driven, and the
selectivity increases with increasing temperature (Fig. 3).
From thedata, the temperature, Tiso,was calculated atwhich the
enantioselectivity balances out and the elution sequence changes
(Table 3). In most cases, Tiso was above 50 ◦C, but for analyte 3 on
Chirobiotic T it was −26 ◦C. These temperatures indicate that lower
temperatures are preferable for the best separation of most of the
analytes,with the exceptionof analyte3on theChirobiotic T,where
positive (H◦) and (S◦) were observed.
4. Conclusions
HPLC methods were developed for the separation of the
enantiomers of monoterpene-based 2-amino carboxylic acids,
using macrocyclic glycopeptide-based CSPs: (i.e., Chirobiotic T,
T2 and TAG). Baseline resolution was achieved in all cases.
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The values of thermodynamic parameters such as the changes
in enthalpy, (H◦), entropy, (S◦), and Gibbs free energy,
(G◦), depended on the structures of the analytes and on the
chiral selectors used. The elution sequence was determined in all
cases, but no general predictive rule could be found to describe the
elution behaviour of these compounds.
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1. Introduction
By virtue of their pharmacological potential, alicyclic
-amino acids are of great interest among synthetic and
medicinal chemists. The naturally occurring -amino acid
cispentacin (1R,2S-2-aminocyclopentanecarboxylic acid), ico-
fungipen (1R,2S-2-amino-4-methylenecyclopentanecarboxylic
acid) and oryzoxymycin (2S,5R,6R-2,6-amino-5-hydroxy-1,3-
cyclohexadiene-1-carbonyloxypropionic acid) are bioactive
compounds with antibacterial and antifungal activities. A number
of cyclic, conformationally restricted -amino acids have been
used as building blocks for the synthesis of new peptides, which
might be of importance in the synthesis of peptide-based drugs
[1–3].
Amino acids containing an isoxazoline moiety have revealed
anti-inﬂuenza activities and antifungal properties. Several isox-
azole carboxylic acids, such as conformationally constrained
aspartate and glutamate analogs, have been reported as enzyme
inhibitors or agents possessing neuroprotective activities [4–7].
Isoxazoline-fused amino acids have served as important precursors
∗ Corresponding author. Tel.: +36 62 544000/3656; fax: +36 62 420505.
E-mail address: apeter@chem.u-szeged.hu (A. Péter).
for the synthesis of novel multisubstituted cyclopentene deriva-
tives with antiviral activities [8–10].
The wide-ranging utility of these compounds requires analyti-
cal methods to check on the stereochemistry of the ﬁnal product.
One of the most frequently applied techniques is chiral high-
performance liquid chromatography (HPLC). HPLC enantiosepara-
tions of -amino acids have been performed by both indirect and
direct methods. In the past decade, chiral derivatizing agents such
as Marfey’s reagent, 2,3,4,6-tetra-O-acetyl--d-glucopyranosyl
isothiocyanate and N-(4-nitrophenoxycarbonyl) phenylalanine
methoxyethyl ester [11], chiral stationary phases (CSPs) such as
macrocyclic glycopeptides [12,13],  quinine derivatives [14] and (+)-
(18-crown-6)-2,3,11,12-tetracarboxylic acid-derivatives [15–19],  a
rapid double derivatization technique with gas chromatography
[20] and (18-crown-6)-2,3,11,12-tetracarboxylic acid as a chiral
NMR  solvating agent have been used for the analysis of -amino
acids enantiomeric composition [21].
Enantioselective retention and separation are inﬂuenced by
temperature [22–29].  In order to investigate the thermodynamic
functions of enantioselective adsorption, van’t Hoff plots were con-
structed, which may  be interpreted in terms of the mechanistic
aspects of chiral recognition:
ln k = −H
◦
RT
+ S
◦
R
+ ln  (1)
0021-9673/$ – see front matter ©  2011 Elsevier B.V. All rights reserved.
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Fig. 1. Structures of isoxazoline-fused 2-aminocyclopentanecarboxylic acids.
in which k is the retention factor, H◦ is the enthalpy of trans-
fer of the solute from the mobile phase to the stationary phase,
S◦ is the entropy of transfer of the solute from the mobile phase
to the stationary phase, R is the gas constant, T is temperature
and  is the ratio of volume of stationary phase (VS) and mobile
phase (VM). The corresponding (H◦) and (S◦) values for the
separated enantiomers can be determined from a modiﬁcation of
Eq. (1):
ln  ˛ = −(H
◦)
RT
+ (S
◦)
R
(2)
where  ˛ is the selectivity factor (  ˛ = k2/k1). If (H◦) is invari-
ant with temperature (i.e. a linear van’t Hoff plot is obtained), this
expression shows that a plot of R ln  ˛ versus 1/T  has a slope of
−(H◦) and an intercept of (S◦).
In the present paper, direct HPLC methods are described for
the separation of enantiomers new cyclic 3-amino acids (Fig. 1),
with the application of macrocyclic glycopeptide-based CSPs. For
comparison purposes, most of the separations were carried out at
constant mobile phase composition. The effects of the mobile phase
composition, the speciﬁc structural features of the analytes and
selectors and temperature on the retention are discussed on the
basis of the experimental data. The elution sequence was deter-
mined in all cases.
2. Experimental
2.1. Chemicals and reagents
Racemic isoxazoline-fused cispentacin stereoisomers were
prepared by 1,3-dipolar cycloaddition of nitrile oxides to
N-Boc-protected ethyl 2-amino-3-cyclopentenecarboxylate
as dipolarophile. The nitrile oxides were generated from
nitroethane or 1-nitropropane in the presence of Boc2O and
4-dimethylaminopyridine (DMAP). When the dipolarophile
underwent cycloaddition in THF at 20 ◦C for 15 h, two regioisomers
and one diastereomer were formed [30]. The isoxazoline-fused
cispentacin enantiomers were prepared from enantiomerically
pure Boc-protected ethyl 2-amino-3-cyclopentenecarboxylate
[31,32]. The cycloadditions were performed similarly as for the
racemic compounds. Under the same experimental conditions
(nitroethane/1-nitropropane, Boc2O and DMAP), the racemic
trans counterparts furnished selectively only one cycloadduct,
which also could be prepared by epimerization at C-5 of the
very minor product. The two  racemic major regioisomers were
epimerized at C-5 with NaOEt in EtOH to give isoxazoline-fused
trans amino esters [33]. These reactions were extended to their
preparation in enantiomerically pure form [31,32]. In the next
step, the earlier-prepared racemic and enantiomerically pure
isoxazoline-fused ethyl 2-amino-cyclopentanecarboxylates were
hydrolysed in the presence of HCl/H2O (2:1) in dioxane to give
the corresponding amino acid derivatives (1a, 1d;  2a,  2d;  3a,  3c;
4a,  4c).
Methanol (MeOH) of HPLC grade was purchased from Schar-
lau (Sentmenat, Spain). Triethylamine (TEA), glacial acetic acid
(AcOH) and other reagents of analytical reagent grade were from
Sigma–Aldrich (St. Louis, MO,  USA). The Milli-Q water was fur-
ther puriﬁed by ﬁltration on a 0.45-m ﬁlter, type HV, Millipore
(Molsheim, France).
All compounds mentioned in Fig. 1 were evaluated with differ-
ent mobile phases. Reversed-phase mobile phases consisted of 0.1%
triethylammonium acetate (TEAA) (pH 4.1)/MeOH = 98/2, 90/10,
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80/20, 60/40, 40/60, 20/80 and 10/90 (v/v), the polar organic phase
(POM) was 100% MeOH, and the polar ionic mobile phase (PIM) was
MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v).
2.2. Apparatus and chromatography
The HPLC measurements were carried out on a Waters HPLC
system consisting of an M-600 low-pressure gradient pump,
an M-996 photodiode-array detector and a Millenium32 Chro-
matography Manager data system; the alternative Waters Breeze
system consisted of a 1525 binary pump, a 487 dual-channel
absorbance detector, a 717 plus autosampler and Breeze data
manager software (both systems from Waters Chromatography,
Milford, MA,  USA). Both chromatographic systems were equipped
with Rheodyne Model 7125 injectors (Cotati, CA, USA) with 20-l
loops.
The macrocyclic glycopeptide-based stationary phases used for
analytical separation were teicoplanin-containing Chirobiotic T and
T2, teicoplanin aglycone-containing Chirobiotic TAG, vancomycin-
containing Chirobiotic V and vancomycin aglycone-containing
Chirobiotic VAG columns, 250 mm  × 4.6 mm I.D., 5-m particle
size (for each column) (Astec, Whippany, NJ, USA). The differences
between the Chirobiotic T and T2 columns are that they are both on
5-m particle size silica gel, but the Chirobiotic T uses a 120 A˚ pore
size material and Chirobiotic T2 uses a 200 A˚ pore material. Also,
the linkage chain on Chirobiotic T2 is approximately twice as long
as that on Chirobiotic T. Hence, the coverage and spacing are dif-
ferent for the two stationary phases. This manifests itself mainly in
the form of steric interaction differences between the two  columns.
2.3. HPLC operating conditions applied for validation process
To determine validation characteristics of the analytical proce-
dure separations were carried out repeatedly for analytes 2a,  2b
on the Chirobiotic TAG CSP with a mobile phase 0.1% TEAA (pH
4.1)/MeOH = 60/40 (v/v) at 25 ◦C and for analytes 3a,  3b on Chirobi-
otic VAG CSP with a mobile phase 100% MeOH at 10 ◦C, at a ﬂow rate
of 0.5 ml  min−1. Analytes 2a,  2b possess an ethyl group side-chain
while analyte 3a,  3b a methyl side-chain. The injection volume was
20 l, while the detector was set at 210 nm.
3. Results and discussion
The analytes in this study (Fig. 1) possess an isoxazoline-fused
cyclopentane skeleton. Besides carboxy and primary amino groups,
analogs 1 and 3 bear a methyl group on position 3, and analogs
2 and 4 an ethyl group on position 3. These differences result in
different steric effects and inﬂuence the hydrophobicity, bulkiness
and rigidity of the molecules, depending on how their atoms are
linked and how capable they are of different interactions with the
selector.
All data relating to the separation of the compounds, includ-
ing the retention factors, separation factors and resolutions for
each analyte on the ﬁve different Chirobiotic columns, are given in
Tables 1 and 2. All the compounds mentioned in Tables 1 and 2 were
evaluated with different mobile phases, with eluent compositions
varied between 0.1% TEAA (pH 4.1)/MeOH = 98/2 and 10/90 (v/v),
100% MeOH and MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v). To simplify
the presentation, Tables 1 and 2 basically list only the columns and
chromatographic results obtained when the enantiomeric separa-
tion was achieved, but for purposes of comparison some results are
presented when no separation occurred. At a given mobile phase
composition, the retention factors were lower on the teicoplanin
CSPs (T and T2) than on the aglycone CSP (TAG) (except for ana-
lytes 1c,  1d;  2c,  2d and 4a,  4b on Chirobiotic T in POM, 1c,  1d;
2c,  2d on Chirobiotic T2 in PIM and POM and 3c,  3d on Chiro-
biotic T in PIM; Table 2). Similar trends, with higher k′ values on
Chirobiotic TAG than on a Chirobiotic T column, were observed by
Berthod et al. [34], D’Acquarica et al. [12] and Péter et al. [35–37] for
unusual -amino acids and cyclic -amino acids. Comparison of the
data for the Chirobiotic T and T2 columns revealed that the reten-
tion factors on Chirobiotic T were in most cases somewhat larger
(Tables 1 and 2). Slightly higher k′ values on Chirobiotic T2 than on
Chirobiotic T were observed by Péter et al. [37] for 3-homoamino
acids.
The effects of the MeOH content of the mobile phase in reversed-
phase mode were investigated on all ﬁve CSPs. In most cases, a
U-shaped retention curve was observed for all analogs. At higher
water content, the retention factor increased with increasing water
content; this was probably due to enhanced hydrophobic interac-
tions between the analyte and the CSP in the water-rich mobile
phases. In the reversed-phase mode, one of the most important
interactions between the analyte and the CSP is the hydropho-
bic interaction inside the “basket” of the glycopeptide. Here, an
increase in k′ at high water content was observed for all ana-
lytes. When the MeOH content of the mobile phase exceeded
∼50%, the retention factor increased. This suggests that the reten-
tion behavior may  be controlled by a mechanism of hydrophilic
interaction chromatography (HILIC) at high MeOH  contents. In this
study, as earlier [38], the inﬂection points and the slopes of the
U-shaped curves at higher and lower MeOH concentrations dif-
fered somewhat for each compound. Different extents of solvation
of the stationary phase during HILIC and under the reversed-
phase conditions may  explain the observed retention behavior.
As regards the variations in the separation factors (˛) and reso-
lutions (RS) with change of MeOH content, no general trends were
observed.
Use of the MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v) mobile phase
system generally resulted in lower retention than with 100% MeOH
(except for analytes 2a,  2b on Chirobiotic T2, 3a,  3b on Chirobiotic
T and TAG, and 4a,  4b on Chirobiotic TAG). However, in a few cases
(especially for analytes 3 and 4), despite the lower k′ values, higher
 ˛ and RS values were obtained, indicating that the level of chiral
discrimination was  better in the polar ionic mode (Table 2).
The structures of the analytes inﬂuenced the chiral recognition.
In the reversed-phase mode methyl or ethyl substitution exhibited
a slight effect on retention and in most cases retention factors of
methyl or the ethyl substituted analogs did not differ considerably.
The position of the methyl or ethyl group inﬂuenced the  ˛ and RS
values. On the teicoplanin-containing CSPs for methyl-substituted
analogs better  ˛ and RS values were obtained in most cases for enan-
tiomers 1a,  1b than for 3a,  3b,  while 3c,  3d were better separated
than 1c,  1d.  Similarly, for ethyl-substituted analogs, 2a,  2b and 4c,
4d exhibited better separation than 4a,  4b and 2c,  2d,  respectively,
on Chirobiotic T, T2 and TAG CSPs.
For comparison of the performances of the macrocyclic
glycopeptide-based columns, separations were carried out with
the same mobile phases (Table 1). Of the three teicoplanin-based
columns Chirobiotic TAG seemed to be more effective in the sepa-
ration of all enantiomers with exception pair of 2a,  2b for which
Chirobiotic T2 and 3a,  3b for which Chirobiotic T was better.
Comparison of the teicoplanin and vancomycin-based selectors
demonstrated that the vancomycin-based CSPs were effective only
in the separation of the enantiomers of 3a,  3b and 4a,  4b (the
enantiomers of 1 and 2 were not separable on Chirobiotic V and
VAG).
In summary, the macrocyclic glycopeptide-based CSPs display a
complementary character. Elution sequences were determined in
all cases. For analytes 1–4 on the Chirobiotic T, T2, TAG, V and VAG
columns, no consistent elution sequence was  observed. Neither the
conﬁguration of the carbon atom attached to the carboxyl group nor
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Table 1
Retention factors of the ﬁrst eluting enantiomer (k1 ′), separation factors (˛), resolutions (RS) and elution sequences of regio- and stereoisomers of isoxazoline-fused cispentacin
analogs in reversed-phase mode.
Compound Column Mobile phase
TEAA/MeOH (v/v)
k1 ′  ˛ RS Elution sequence
1a,  1b T 90/10 2.63 1.00 0.00 –
60/40 2.31 1.01 0.20 a < b
10/90  4.76 1.07 0.80 a < b
T2  90/10 0.93 1.10 0.70 a < b
60/40  0.91 1.13 1.00 a < b
10/90 2.96 1.16 1.65 a < b
TAG 90/10 4.31 1.19 1.80 a < b
60/40 2.73 1.26 2.25 a < b
10/90  4.76 1.33 3.25 a < b
1c,  1d T 90/10 1.85 1.00 0.00 –
10/90 7.51 1.01 0.20 d < c
T2 90/10 1.39 1.00 0.00 –
10/90 8.16 1.04 0.65 d < c
TAG 90/10 3.26 1.06 0.70 c < d
10/90 8.20 1.02 0.20 c < d
2a,  2b T 90/10 1.88 1.06 0.65 a < b
60/40  1.77 1.09 0.85 a < b
10/90  3.75 1.07 1.00 a < b
T2  90/10 1.07 1.14 0.80 a < b
60/40  0.95 1.18 1.20 a < b
10/90 2.28 1.24 2.60 a < b
TAG  90/10 5.63 1.18 1.85 a < b
60/40 2.92 1.30 2.25 a < b
10/90  4.65 1.18 1.90 a < b
2c,  2d T 90/10 2.55 1.00 0.00 –
10/90 6.52 1.00 0.00 –
T2 90/10 1.64 1.00 0.00 –
10/90 6.64 1.03 0.60 d < c
TAG 90/10 4.98 1.10 1.40 c < d
60/40  4.52 1.09 1.55 c < d
10/90  6.95 1.03 0.40 c < d
3a,  3b T 90/10 2.09 1.00 0.00 –
10/90 5.01 1.17 1.45 a < b
T2  90/10 1.11 1.00 0.00 –
10/90 3.66 1.00 0.00 –
TAG  90/10 6.09 1.09 1.00 b < a
10/90 5.66 1.09 0.85 b < a
V  90/10 0.30 1.15 0.55 b < a
10/90 0.98 1.36 2.95 b < a
VAG 90/10 0.57 1.18 1.10 b < a
10/90 1.18 1.31 2.70 b < a
3c,  3d T 90/10 1.90 1.13 1.30 d < c
10/90 5.71 1.02 0.30 d < c
T2  90/10 1.07 1.16 1.00 d < c
10/90 3.23 1.14 1.65 d < c
TAG  90/10 3.18 1.06 0.60 c < d
10/90  5.75 1.24 2.15 c < d
V  90/10 0.16 1.25 0.60 d < c
10/90 0.78 1.13 0.80 d < c
VAG  90/10 0.54 1.00 0.00 –
10/90 1.63 1.06 0.60 d < c
4a,  4b T 90/10 2.64 1.00 0.00 –
10/90 4.82 1.17 1.65 a < b
T2  90/10 1.10 1.00 0.00 –
10/90 3.72 1.00 0.00 –
TAG  90/10 7.86 1.09 0.90 b < a
10/90 4.91 1.18 2.15 b < a
V  90/10 0.45 1.09 0.45 b < a
10/90 0.92 1.35 2.60 b < a
VAG  90/10 0.81 1.16 1.35 b < a
10/90 1.08 1.31 3.00 b < a
4c,  4d T 10/90 4.50 1.08 1.10 d < c
T2  10/90 2.88 1.14 1.55 d < c
TAG  10/90 4.60 1.27 2.50 c < d
V  10/90 0.71 1.08 0.50 d < c
VAG 10/90 1.47 1.05 0.55 d < c
Chromatographic conditions: selectors and columns. T and T2,  teicoplanin, Chirobiotic T and T2; TAG, teicoplanin aglycone, Chirobiotic TAG; V, vancomycin, Chirobiotic V;
VAG,  vancomycin aglycone, Chirobiotic VAG; mobile phase, 0.1% triethylammonium acetate (pH 4.1)/MeOH (v/v); ﬂow rate, 0.5 ml min−1; detection, 210 nm.
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Table 2
Retention factors of the ﬁrst eluting enantiomer (k1 ′), separation factors (˛), resolutions (RS) and elution sequences of regio- and stereoisomers of isoxazoline-fused cispentacin
analogs in polar organic and polar ionic modes.
Compound Column Mobile phase MeOH (100%)
MeOH/AcOH/TEA (v/v/v)
k1 ′  ˛ RS Elution sequence
1a,  1b T 100 9.29 1.11 0.90 b < a
100/0.1/0.1 7.78 1.03 0.35 a < b
T2  100 5.23 1.16 0.90 a < b
100/0.1/0.1 4.91 1.00 0.00 –
TAG  100 11.91 1.05 0.30 b < a
100/0.1/0.1 8.16 1.00 0.00 –
1c,  1d T 100 14.70 1.04 0.40 d < c
100/0.1/0.1 7.41 1.04 0.95 c < d
T2  100 16.65 1.04 0.65 d < c
100/0.1/0.1 7.78 1.07 0.30 d < c
TAG  100 7.48 1.00 0.00 –
100/0.1/0.1 7.45 1.00 0.00 –
2a,  2b T 100 7.30 1.00 0.00 –
100/0.1/0.1 6.66 1.02 0.25 a < b
T2  100 4.19 1.24 1.40 a < b
100/0.1/0.1 4.91 1.21 1.20 a < b
TAG  100 12.91 1.00 0.00 –
100/0.1/0.1 11.01 1.26 1.20 a < b
2c,  2d T 100 16.59 1.00 0.00 –
100/0.1/0.1 6.41 1.00 0.00 –
T2  100 14.49 1.17 1.00 d < c
100/0.1/0.1 9.59 1.03 0.40 d < c
TAG  100 10.14 1.00 0.00 –
100/0.1/0.1 7.38 1.00 0.00 –
3a,  3b T 100 7.27 1.46 3.75 a < b
100/0.1/0.1 9.13 1.21 1.65 a < b
T2  100 7.16 1.00 0.00 –
100/0.1/0.1 5.92 1.03 0.25 b < a
TAG  100 11.63 1.29 1.45 a < b
100/0.1/0.1 15.49 1.08 0.50 b < a
V  100 1.95 1.40 2.70 b < a
100/0.1/0.1 1.60 1.44 3.05 b < a
VAG 100 2.41 1.34 3.50 b < a
100/0.1/0.1 1.73 1.36 3.10 b < a
3c,  3d T 100 11.76 1.03 0.25 c < d
100/0.1/0.1 7.85 1.05 0.45 c < d
T2  100 5.57 1.29 2.00 d < c
100/0.1/0.1 3.19 1.23 1.35 d < c
TAG  100 14.75 1.06 0.35 c < d
100/0.1/0.1 6.00 1.09 1.25 c < d
V 100 1.74 1.14 1.10 d < c
100/0.1/0.1 1.50 1.00 0.00 –
VAG 100 3.45 1.08 0.75 d < c
100/0.1/0.1 1.58 1.14 0.95 d < c
4a,  4b T 100 10.06 1.20 1.70 a < b
100/0.1/0.1 7.67 1.11 0.95 a < b
T2  100 7.08 1.00 0.00 –
100/0.1/0.1 6.46 1.00 0.00 –
TAG  100 9.25 1.24 0.90 b < a
100/0.1/0.1 11.07 1.25 1.50 b < a
V  100 1.81 1.38 2.20 b < a
100/0.1/0.1 1.47 1.41 3.30 b < a
VAG  100 2.18 1.34 3.15 b < a
100/0.1/0.1 1.49 1.38 3.10 b < a
4c,  4d T 100 8.76 1.09 0.65 d < c
100/0.1/0.1 5.74 1.12 1.15 d < c
T2  100 4.90 1.26 1.75 d < c
100/0.1/0.1 4.54 1.06 0.40 c < d
TAG  100 13.94 1.03 0.30 c < d
100/0.1/0.1 6.54 1.14 0.50 c < d
V  100 1.51 1.09 0.45 d < c
100/0.1/0.1 1.09 1.12 1.30 d < c
VAG  100 3.24 1.06 0.50 d < c
100/0.1/0.1 1.28 1.10 0.55 d < c
Chromatographic conditions: selectors and columns. T and T2, teicoplanin, Chirobiotic T and T2; TAG, teicoplanin aglycone, Chirobiotic TAG; V, vancomycin, Chirobiotic V;
VAG,  vancomycin aglycone, Chirobiotic VAG; mobile phase, 0.1% triethylammonium acetate (pH 4.1)/MeOH (v/v); ﬂow rate, 0.5 ml  min−1; detection. 210 nm.
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Fig. 2. Separation of four stereoisomers of isoxazoline-fused cispentacin derivatives. Chromatographic conditions: column, for analytes 1 and 2 Chirobiotic TAG, for 3
Chirobiotic VAG, and for 4 Chirobiotic V; mobile phase, for analyte 1, 0.1% TEAA (pH 4.1)/MeOH = 60/40 (v/v), for 2, 0.1% TEAA (pH 4.1)/MeOH (v/v) = 80/20 (v/v); for 3, MeOH,
100%,  and for 4, MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v); temperature, 25 ◦C for analytes 1 and 2, and 10 ◦C for analytes 3 and 4; ﬂow rate, 0.5 ml  min−1; detection, 210 nm.
that of the carbon atom attached to the amino group determined
the elution sequence, and in some cases the elution sequence also
differed when the mobile phase was changed from reversed-phase
to polar organic or polar ionic mode.
3.1. Separation of four enantiomers of isoxazoline-fused
2-aminocyclopentanecarboxylic acids
Since the biological activities of isoxazoline-fused 2-
aminocyclopentanecarboxylic acid analogs depend strongly
on their conﬁgurations, it is a basic task to separate and identify
not only the enantiomers, but also the diastereomers in one chro-
matographic run. The data listed in Table 1 reveal that separation
of the four stereoisomers could be achieved in only a few cases.
To attain separation of the four stereoisomers in one chromato-
graphic run, the separation was optimized by variation of the CSPs
and mobile phase composition. Fig. 2 and Table 3 illustrate the
enantioseparation of all four stereoisomers of isoxazoline-fused
2-aminocyclopentanecarboxylic acid analogs.
3.2. Effects of temperature and thermodynamic parameters
In order to investigate the effects of temperature on the chro-
matographic parameters, a variable-temperature study was carried
out on Chirobiotic T and TAG columns over the temperature range
5–45 ◦C (in 10 ◦C increments). Experimental data for the mobile
phase 0.1% TEAA (pH 4.1)/MeOH = 10/90 (v/v) are listed in Table 4.
A comparison of the retention factors in Table 4 reveals that all of
the recorded values decreased with increasing temperature. It is
evident that an increase in the separation temperature lowers the
separation factor, ˛. However, for analytes 3a,  3b on the Chirobi-
otic TAG column,  ˛ (and RS) increased with increasing temperature.
Increasing temperature may  improve the peak symmetry and efﬁ-
ciency, and therefore the resolution may  also improve.
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Table 3
Chromatographic data, retention factors and resolutions for separation of four stereoisomers of isoxazoline-fused cispentacin derivatives on Chirobiotic TAG, VAG and V
columns.
Analyte Column Mobile phase k1 ′ k2 ′ k3 ′ k4 ′ RS1 RS2 RS3 Elution sequence
1 TAG a 2.73 3.45 3.95 4.13 3.10 2.05 0.80 a < b < c < d
2 TAG  b 2.89 3.28 3.58 4.05 1.95 1.40 2.15 a < b < c < d
3  VAG c 2.53 2.93 3.21 3.50 1.95 1.45 1.80 b < d < c < a
4 V  d 1.27 1.43 1.83 2.67 0.90 1.95 3.30 d < c < b < a
Chromatographic conditions: mobile phase, a, 0.1% TEAA (pH 4.1)/MeOH = 60/40 (v/v), b, 0.1% TEAA (pH 4.1)/MeOH (v/v) = 80/20 (v/v); c, MeOH, 100%, d,
MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v); temperature, 25 ◦C for analytes 1 and 2, 10 ◦C for analytes 3 and 4; ﬂow rate, 0.5 ml  min−1; detection, 210 nm.
Table  4
Retention factor of ﬁrst-eluting enantiomer (k′), separation factor (˛) and resolution (Rs) of regio- and stereoisomers of isoxazoline-fused cispentacin analogs 1–4 as a function
of  temperature.
Analyte Column k1 ′ , ˛, RS Temperature (◦C)
5 15 25 35 45
1a,  1b T k1 ′ 5.20 4.77 4.23 3.80 3.47
˛  1.08 1.06 1.04 1.03 1.01
RS 0.80 0.70 0.40 0.30 0.20
TAG k1 ′ 6.18 5.39 4.76 4.19 3.59
˛  1.47 1.40 1.33 1.26 1.21
RS 3.40 3.35 3.30 3.15 2.65
1c,  1da T k1 ′ 8.22 7.42 6.82 6.45 5.86
˛  1.02 1.01 1.00 1.00 1.00
RS 0.20 0.10 0.00 0.00 0.00
TAG k1 ′ 9.02 7.96 7.02 6.07 5.46
˛  1.02 1.02 1.02 1.02 1.01
RS 0.30 0.25 0.20 0.20 0.15
2a,  2b T k1 ′ 4.66 4.26 3.82 3.39 3.12
˛  1.12 1.09 1.06 1.04 1.02
RS 1.05 0.85 0.75 0.55 0.35
TAG  k1 ′ 6.05 5.26 4.65 4.06 3.46
˛  1.25 1.22 1.18 1.14 1.12
RS 2.05 2.00 1.90 1.80 1.45
2c,  2d T k1 ′ 7.65 7.01 6.52 5.97 5.56
˛  1.02 1.01 1.00 1.00 1.00
RS 0.15 0.10 0.00 0.00 0.00
TAG k1 ′ 8.86 7.87 6.95 5.96 5.47
˛  1.03 1.03 1.03 1.03 1.02
RS 0.40 0.35 0.30 0.25 0.20
3a,  3b T k1 ′ 6.41 5.72 5.01 4.34 3.83
˛  1.29 1.21 1.17 1.12 1.08
RS 1.90 1.60 1.45 1.20 0.70
TAG k1 ′ 9.03 7.53 6.48 5.52 4.65
˛  1.04 1.06 1.08 1.10 1.11
RS 0.15 0.45 0.85 0.95 1.00
3c,  3d T k1 ′ 6.73 6.31 5.71 5.17 4.82
˛  1.03 1.02 1.02 1.01 1.01
RS 0.40 0.30 0.25 0.20 0.10
TAG  k1 ′ 6.02 5.40 4.62 4.10 3.73
˛  1.25 1.25 1.24 1.23 1.21
RS 2.40 2.30 2.15 1.95 1.90
4a,  4b T k1 ′ 5.99 5.28 4.54 3.99 3.59
˛ 1.15 1.10 1.08 1.05 1.03
RS 1.55 1.05 1.00 0.70 0.30
TAG  k1 ′ 6.38 5.54 4.82 4.12 3.50
˛  1.19 1.18 1.17 1.17 1.16
RS 1.40 1.75 1.80 2.00 2.05
4c,  4d T k1 ′ 5.67 5.33 4.89 4.42 4.12
˛  1.10 1.08 1.07 1.06 1.05
RS 0.85 0.75 0.65 0.60 0.50
TAG  k1 ′ 6.52 5.79 5.18 4.55 4.21
˛  1.29 1.27 1.26 1.24 1.22
RS 2.70 2.55 2.50 2.45 2.30
Chromatographic conditions: column, T, Chirobiotic T, TAG, Chirobiotic TAG; mobile phase, 0.1% TEAA (pH 4.1)/MeOH = 10/90 (v/v); ﬂow rate, 0.5 ml  min−1; detection, 210 nm.
a For analyte 1c,  1d at 55 ◦C: k1(c) ′ , 5.63; k2(d) ′ , 5.88; ˛, 1.05; RS , 0.35.
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Table 5
Thermodynamic parameters, H◦ , S◦*, (H◦), (S◦), (G◦), correlation coefﬁcients (R2) and Tiso temperature of analytes 1–4 on Chirobiotic T and TAG columns.
Analyte Column Stereo-
isomer
−H◦
(kJ mol−1)
−S◦*
(J mol−1 K−1)
Correlation
coefﬁcient
(R2)
−(H◦)
(kJ mol−1)
−(S◦)
(J mol−1 K−1)
−(G◦)
(288 K)
(kJ mol−1)
Tiso (◦C)
1a,  1b T 1 7.7 13.7 0.9961 1.2 3.7 0.2 55
2 8.9  17.4 0.9974
TAG 1 9.8 20.1 0.9949 3.5 9.5 0.8 98
2  13.4 29.6 0.9977
1c,  1d T 1 6.0 4.2 0.9940 0.7 2.2 0.1 36
2 6.4  5.3 0.9930
TAG 1 9.4 15.4 0.9976 0.2 0.4 1.0 147
2 9.6  15.8 0.9977
2a,  2b T 1 7.6 14.4 0.9953 1.6 4.7 0.2 58
2  9.1 19.1 0.9973
TAG 1 10.1 21.3 0.9942 2.1 5.8 0.5 96
2  12.3 27.1 0.9964
2c,  2d T 1 5.9 4.2 0.9985 0.6 2.0 0.1 37
2  6.2 5.3 0.9995
TAG 1 9.1 14.6 0.9952 0.2 0.5 0.1 152
2  9.3 15.1 0.9953
3a,  3b T 1 9.6 19.0 0.9952 3.2 9.4 0.5 66
2  12.8 28.4 0.9989
TAG 1 12.1 25.0 0.9980 −1.2 −4.7 0.2 −15
2  10.9 20.3 0.9969
3c,  3d T 1 6.4 7.0 0.9923 0.3 1.0 0.1 67
2 6.7  8.0 0.9926
TAG 1 9.1 17.6 0.9957 0.8 0.7 0.5 745
2 9.8  18.4 0.9966
4a,  4b T 1 9.6 19.6 0.9986 2.0 6.2 0.3 55
2 11.6  25.7 0.9993
TAG 1 10.9 23.5 0.9955 0.6 0.6 0.4 740
2  11.4 24.1 0.9956
4c,  4d T 1 6.1 7.2 0.9901 0.8 2.2 0.2 100
2  6.9 9.4 0.9927
TAG 1 8.2 13.9 0.9973 1.0 1.3 0.6 450
2 9.2  15.2 0.9979
Mobile phase, 0.1% TEAA (pH 4.1)/MeOH = 10/90 (v/v); S◦* = S◦ + ln ˚, where  ˚ is the phase ratio; R2, correlation coefﬁcient of van’t Hoff plot, ln k −1/T curves; Tiso ,
temperature of ln k − 1/T  curves where enantioselectivity cancels.
Thermodynamic parameters were obtained from van’t Hoff
plots [Eq. (1)]. The H◦ and S◦* values calculated from the slopes
and intercepts of these plots for the enantiomers on Chirobiotic
T and TAG columns were negative (Table 5). The second-eluting
enantiomers with (the exception of 3a,  3b on Chirobiotic TAG)
exhibited more negative H◦ and S◦* values; it is likely that they
have fewer degrees of freedom on the CSP, i.e. they are held at
more points or are less able to move or rotate. It is widely accepted
that both enantiomers undergo the same non-speciﬁc interactions,
whereas the more strongly retained one is subject to additional
stereospeciﬁc interactions. Moreover, it was observed that H◦1
and H◦2, and in parallel S◦*1 and S◦*2, for the Chirobiotic T
column were in most cases less negative than those for the Chi-
robiotic TAG column. This may  be due to the fact that the latter
does not contain sugar units, and this may  promote the interaction
between the analyte and the CSP.
For the four analytes, the c, d enantiomers exhibited smaller,
and the a, b enantiomers larger −H◦ and −S◦* values on both
CSPs. The trans conﬁguration of the amino and carboxy groups in
the c, d enantiomer pairs may  sterically inhibit their ﬁt and orienta-
tion in the cavity, and the separation was thermodynamically less
favorable. The largest −H◦ and −S◦* values for all analytes on
the TAG CSP indicate that separation on it were sterically favorable.
The differences in the changes in enthalpy and entropy, (H◦)
and (S◦), are also presented in Table 5. The −(H◦) values on
the Chirobiotic T CSP ranged from −0.3 to −3.2 kJ mol−1 and on
the Chirobiotic TAG CSP from 1.2 to −3.5 kJ mol−1. The interactions
of 1a,  1b with the Chirobiotic TAG CSP were characterized by the
highest negative (H◦) value, while 3a,  3b on Chirobiotic TAG
exhibited a positive (H◦). The trends in the change in −(S◦)
showed that 1a,  1b on Chirobiotic TAG displayed the largest nega-
tive entropies, and on the Chirobiotic T CSP −(S◦) ranged from
−1.0 to −9.4 J mol−1 K−1 and on the Chirobiotic TAG CSP from 4.7
to −9.5 J mol−1 K−1 (Table 5). For 3a,  3b,  similarly to (H◦) on the
Chirobiotic TAG column, (S◦) was positive.
The thermodynamic parameter −(G◦) suggests that TAG
induces highly efﬁcient binding to the selector, as reﬂected by
the larger negative (G◦) values for 1–4 on Chirobiotic TAG. For
analytes 1–4 on both columns (with the exception of 3a,  3b on Chi-
robiotic TAG), selector–selectand complex formation proceeds via
multiple intermolecular interactions and was generally exother-
mic, with a corresponding negative entropic contribution.
For 3a,  3b on Chirobiotic TAG, the positive (S◦) compensated
the positive (H◦) and resulted in a negative (G◦). In this tem-
perature range, enantioresolution is entropically driven, and the
selectivity increases with increasing temperature (Table 5).
The data were used to calculate the temperature, Tiso, at
which point the enantioselectivity and the elution sequence
changed (Table 5). In most cases, Tiso was considerably higher
than room temperature; enthalpically driven enantioseparation
was  obtained. For 3a,  3b on Chirobiotic TAG, Tiso was  −15 ◦C,
positive (H◦) and (S◦) were observed in the investigated
temperature range and the selectivity increased with increasing
temperature.
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Fig. 3. Separation of minor enantiomers of 2a,  2b and 3a,  3b when it is present in an excess of the major isomer. Chromatographic conditions: column, Chirobiotic VAG for
2a,  2b,  and Chirobiotic V for 3a,  3b;  mobile phase for 2a,  2b 0.1% TEAA (pH 4.1)/MeOH (v/v) = 10/90 (v/v) and for 3a,  3b MeOH/AcOH/TEA = 100/0.1/0.1 (v/v/v); temperature,
25 ◦C; ﬂow rate, 0.5 ml  min−1; detection, 210 nm.
For 1c,  1d and 2c,  2d,  on the Chirobiotic T CSP, Tiso was  37 ◦C.
For 1c,  1d on the Chirobiotic T column with the 0.1% TEAA (pH
4.1)/MeOH = 10/90 (v/v) mobile phase composition, on increase of
the temperature from 5 ◦C to 55 ◦C,  ˛ ﬁrst decreased; then, after
a domain where no separation occurred,  ˛ slightly increased with
increasing temperature at 55 ◦C and the elution sequence changed
(Table 4). In a domain around the isoenantioselective tempera-
ture, the separation of enantiomers could not be obtained. This
domain may  be referred to as a “temperature-induced blind zone”
in chiral recognition [39]. Outside the blind zone, enthalpically or
entropically driven enantioseparation can be observed. It should
be mentioned that peak inversions on temperature changes were
generally observed only for separations with marginal enantiose-
lectivity [40–43].
4. Method validation
4.1. Linearity
Solution of the racemates were prepared at six different con-
centration levels, from 1 to 100 g ml−1 for analytes 2a,  2b and
3a, 3b,  respectively. Three parallel injections of each solution were
made under the chromatographic conditions described above. The
peak area response of the ﬁrst and the second eluting enantiomers
was plotted against the corresponding concentration and the lin-
ear regression was computed by the least square method using
Microsoft Excel program. Very good linearity was observed in
the investigated concentration range with the following regres-
sion equations: for 2a,  y = 1.93 × 106x + 3385 (R2 = 0.9989), for 2b,
y = 1.85 × 106x + 3263 (R2 = 0.9997), for 3a,  y = 9.56 × 106x + 2574
(R2 = 0.9990) and for 3b,  y = 1.00 × 107x + 2656 (R2 = 0.9987). (The
difference of the regression parameters of the enantiomers were
within the standard error.)
4.2. Limit of detection (LOD) and limit of quantitation (LOQ)
LOD and LOQ were determined based on the calibration curve
according to the ICH guidelines using the S/N ratio equal to 3 and
10, respectively [44]. LOD was 5 g ml−1 and 2.5 g ml−1, while
LOQ 16 g ml−1 and 8.0 g ml−1 for 2a,  2b and 3a,  3b,  respectively.
Further, the determination limit for the minor isomer is less than
0.1% when it is present in an excess of the major isomer (Fig. 3).
4.3. Precision
Replicate HPLC analysis showed that the relative standard devi-
ation were no more than 5% for the peak area response and less
than 1.8% for the retention time.
5. Conclusions
The enantiomeric separations of isoxazoline-fused 2-
aminocyclopentanecarboxylic acid analogs were investigated
using macrocyclic glycopeptide-based CSPs, i.e. Chirobiotic T, T2,
TAG, V and VAG columns. The separations could be accomplished
in reversed-phase mode using 0.1% TEAA (pH 4.1)/MeOH mobile
phases with different compositions. Of the ﬁve Chirobiotic columns,
Chirobiotic T and TAG appeared most suitable for the enantiosepa-
ration of isoxazoline-fused 2-aminocyclopentanecarboxylic acids.
The values of thermodynamic parameters such as the changes
in enthalpy, (H◦), entropy, (S◦), and Gibbs free energy,
(G◦), depended on the structures of the analytes and on the
chiral selectors used. The elution sequence was determined in all
cases, but no general predictive rule could be found to describe the
elution behavior of these compounds.
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High-Performance Liquid Chromatographic Enantioseparation of
Unusual Isoxazoline-Fused 2-Aminocyclopentanecarboxylic Acids on
(+)-(18-Crown-6)-2,3,11,12-Tetracarboxylic Acid-Based Chiral
Stationary Phases
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ABSTRACT The enantiomers of four unusual isoxazoline-fused 2-aminocyclopentanecar-
boxylic acids were directly separated on chiral stationary phases containing (+)-(18-crown-6)-
2,3,11,12-tetracarboxylic acid as chiral selector. The nature of the alcoholic modiﬁer (MeOH,
EtOH, IPA) exerted a great effect on the retention, whereas the selectivity and resolution did
not change substantially. Two types of dependence of retention on alcohol content were
detected: k1 increased continuously with increasing alcohol content or a U-shaped retention
curve was observed. A comparison of the chromatographic data obtained with HCOOH, AcOH,
TFA, HClO4, H2SO4, or H3PO4 as acidic modiﬁer at a constant concentration demonstrated that
in most cases, larger k values were obtained on the application of AcOH or HCOOH, and an
increase of the acid content resulted in a decrease of retention. Some mechanistic aspects of
the chiral recognition process are discussed with respect to the structures of the analytes and
selector. The sequence of elution of the enantiomers was determined in all cases. Chirality
24:817-824, 2012. © 2012 Wiley Periodicals, Inc.
KEY WORDS: column liquid chromatography; enantiomer separation; isoxazoline-fused
2-aminocyclopentanecarboxylic acids(+)-(18-crown-6)-2,3,11,12-tetracarboxylic
acid-based chiral stationary phases
INTRODUCTION
As a consequence of their pharmacological potential,
alicyclic b-amino acids are currently a hot topic in medicinal
chemistry. The natural b-amino acid cispentacin ([1R,2S]-2-
aminocyclopentanecarboxylic acid), icofungipen ([1R,2S]-2-amino-
4-methylenecyclopentanecarboxylic acid) and oryzoxymycin
([S]-2-[[5R,6R]-6-amino-5-hydroxycyclohexa-1,3-dienecarbonyloxy]
propanoic acid) are pharmacologically important compounds
with strong antibacterial and antifungal activities. In the
synthesis of peptide-based drugs, many cyclic, conformation-
ally constrained b-amino acids may serve as building blocks.1–3
Amino acids with an isoxazoline moiety are important
antiviral and antifungal agents. Some isoxazole ring-containing
carboxylic acids, as conformationally restricted aspartate and
glutamate analogs, are known as enzyme inhibitors with
neuroprotective properties.4–7 Moreover, isoxazoline-fused
amino acids may function as important precursors for the
synthesis of novel highly substituted cycloalkane derivatives
with antiviral properties.8–10
Because the biological and physicochemical properties of
amino acids are strongly related to the stereochemistry, it is
very important to have at hand effective analytical methods
that are suitable for the separation and identiﬁcation of the
enantiomers. Among the possible methods, enantioselective
high-performance liquid chromatography (HPLC) is routinely
used for the discrimination of enantiomers. HPLC enantiose-
parations of b-amino acids have been performed by both indi-
rect and direct methods. In the last decade, chiral derivatizing
agents11 and chiral stationary phases (CSPs) such as macro-
cyclic glycopeptides,12,13 quinine derivatives,14 and (+)-(18-
crown-6)-2,3,11,12-tetracarboxylic acid derivatives15–19 as CSPs
and as a chiral NMR solvating agent have been used for analy-
sis of the enantiomeric composition of b-amino acids.20 Very
recently, macrocyclic glycopeptides have been applied for the
enantioseparation of isoxazoline-fused 2-aminocyclopentane-
carboxylic acids.21
In the present paper, direct HPLC methods are described
for the separation of enantiomers of new cyclic b3-amino acids
(Fig. 1), with the application of two different (+)-(18-crown-6)-
2,3,11,12-tetracarboxylic acid-based CSPs (Fig. 2). All analytes
were separated with different mobile phase compositions
involving H2O/alcohol/acid systems. The effects of the nature
and concentration of the mobile phase additives (alcoholic and
acidic modiﬁers) and the speciﬁc structural features of the
analytes and selectors on the separation are discussed on the
basis of the experimental data. The elution sequence was
determined in all cases.
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EXPERIMENTAL
Synthesis of Isoxazoline-Fused
2-Aminocyclopentanecarboxylic Acids
Racemic isoxazoline-fused cispentacin regioisomers and stereoisomers
were synthetized from N-Boc-protected ethyl 2-amino-3-cyclopentenecar-
boxylate in reactions with nitrile oxides, through 1,3-dipolar cycloaddition.
The nitrile oxides were generated from nitroethane or 1-nitropropane in the
presence of di-t-butyl dicarbonate (Boc2O) and 4-dimethylaminopyridine
(DMAP). When the cycloaddition was performed in THF at 20 C for
15 h, the reaction resulted in two regioisomers and one diastereoisomer.22
The isoxazoline-fused cispentacin enantiomers were prepared from the
N-Boc-protected ethyl 2-amino-3-cyclopentenecarboxylate enantiomer.5,23,24
The cycloadditions were achieved similarly as for the racemic compounds.
Under the same experimental conditions (nitroethane/1-nitropropane,
Boc2O and DMAP), the racemic trans counterparts afforded selectively
only one cycloadduct, which was also prepared by epimerization at C-5 of
the very minor product. The two racemic major regioisomers were epimer-
ized at C-5 in the presence of sodium ethoxide in ethanol (EtOH), giving
the corresponding isoxazoline-fused trans amino esters.25 The aforemen-
tioned reactions were also extended to the synthesis of these derivatives
in enantiomerically enriched form.23,24 In the ﬁnal step, the earlier-prepared
racemic and enantiomerically pure isoxazoline-fused ethyl 2-amino-
cyclopentanecarboxylates were submitted to hydrolysis in the presence
Fig. 1. Structures of isoxazoline-fused 2-aminocyclopentanecarboxylic acids.
Fig. 2. Structures of chiral stationary phase 1 (CSP1) and chiral stationary phase 2 (CSP2).
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of HCl/H2O (2:1) in dioxane to afford the corresponding amino acid
derivatives (1a, 1d; 2a, 2d; 3a, 3c; 4a, 4c).
Chemicals and Reagents
Methanol (MeOH), EtOH, and 2-propanol (IPA) of HPLC grade were
purchased from Scharlau (Sentmenat, Spain). Formic acid (HCOOH),
glacial acetic acid (AcOH), triﬂuoroacetic acid (TFA), sulfuric acid
(H2SO4), perchloric acid (HClO4), phosphoric acid (H3PO4), and other
reagents of analytical reagent grade were from Sigma-Aldrich (St. Louis,
MO, USA). Milli-Q water was further puriﬁed by ﬁltration on a 0.45-mm
ﬁlter, type HV, Millipore (Molsheim, France).
Chiral resolution of all the compounds shown in Figure 1 was investi-
gated using mobile phases of H2O/MeOH/acid, H2O/EtOH/acid, and
H2O/IPA/acid in different ratios, where acid in most cases was AcOH.
Apparatus and Chromatography
The HPLC measurements were carried out on a Waters Breeze system
consisting of a 1525 binary pump, a 487 dual-channel absorbance detector,
a 717 plus autosampler, and Breeze data manager software (Waters
Chromatography, Milford, MA, USA). The chromatographic systems were
equipped with a Rheodyne Model 7125 injector (Cotati, CA, USA) with
20-ml loops.
Two different (+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid-based CSPs
were used for analytical separations (Fig. 2). CSP1 was prepared via a
method described earlier,26 except for the use of Kromasil aminopropylsi-
lica gel (KromasilWNH2, 5mm) instead of Rainan AMINO silica gel, whereas
for CSP2, a long 11-methylene-unit spacer27 was applied. All silica gels had a
particle size of 5mm and were packed in a 150 4.0mm I.D. column. The
differences in the two CSPs arise from the different chain length of spacers
(3-methylene or 11-methylene units) and the end capping procedure
(Fig. 2).
RESULTS AND DISCUSSION
The analytes in this study (Fig. 1) possess an isoxazoline-
fused cyclopentane skeleton. Besides carboxy and primary
amino groups, analogs 1 and 3 bear a methyl group on C-3,
in contrast with an ethyl group on C-3 in analogs 2 and 4.
This results in different steric effects, inﬂuencing the hydro-
phobicity, bulkiness, and rigidity of the molecules, and hence
their interactions with the selector.
For such columns, an acidic modiﬁer may be added to the
mobile phase to protonate the primary amino group of the
analyte. Stereoselective complexation of the resulting primary
ammonium ions (R–NH3+) inside the cavity of the crown ether
ring of the CSP has been suggested to be essential for chiral
recognition.28 Besides these interactions, H-bonding, hydro-
phobic, dipole–dipole, steric, among others, interactions
should likewise be taken into account. Lee et al.29 reported
that the high enantioselectivity of this type of CSP for a-amino
acids was due to the H-bonding between one carboxylic acid
in the CSP and a carbonyl group oxygen in the amino acid.
Effects of the Nature and Content of the Alcoholic Modiﬁer
in the Mobile Phase
On the two crown ether-based columns, the results of the
separation of the enantiomers of isoxazoline-fused 2-aminocy-
clopentanecarboxylic acids were evaluated with different
mobile phases consisting of H2O/alcohol/acid mixtures,
where the alcohol was MeOH, EtOH, or IPA, whereas acid
in most cases was AcOH. To simplify the presentation and to
reduce the huge number of data, Table 1 lists chromatographic
data (k1, a, and RS) obtained on CSP1 and k1 on CSP2 when
H2O/MeOH/AcOH (90/10/10, 70/30/10, 50/50/10, 30/70/10,
10/90/10, and 5/95/10 (v/v/mM)) mobile phases were
applied and the ﬁnal concentration of AcOH was 10.0mM.
Investigation of the effects of the alcohol content (MeOH,
EtOH or IPA) of the mobile phase revealed two types of
dependence. In MeOH-containing mobile phases for analytes
2c,2d, 3, and 4, k1 increased continuously with increasing
MeOH content, whereas for analytes 1a,1b, 1c,1d, and
2a,2b on CSP1 and for all analytes on CSP2, a U-shaped re-
tention curve was observed (Table 1). In the EtOH-containing
and IPA-containing mobile phases, k1 increased continuously
with increasing alcohol content (data not shown). An increase
in k1 with increasing alcohol content suggests that the
retention behavior may be controlled by a mechanism of
hydrophilic interaction chromatography (HILIC) at higher
alcohol contents. Different extents of solvation of the CSP
during HILIC (and under the reversed phase) conditions
may explain the observed retention behavior. As concerns
the U-shaped retention curve, the increase in the retention
factor with increasing water content was probably due to
enhanced hydrophobic interactions between the analyte and
the CSP in the water-rich mobile phase. When the alcohol
content of the mobile phase exceeded ~30–50%, the retention
factor increased. The inﬂection points and the slopes of the
U-shaped curves at higher and lower alcohol concentrations
differed somewhat for each compound. As regards the varia-
tions in the separation factors (a) and resolutions (RS) with
change of alcohol content, no general trends were observed.
In the H2O/MeOH/AcOH eluent system, k1 was generally
larger on CSP1 when the alcohol content was larger and on
CSP2 when the H2O content was larger (1c,1d was exception)
(Table 1). In the former case, the more polar CSP1 favors the
HILIC interactions resulting larger k1 in alcohol rich mobile
phase, whereas in the latter case, the more apolar CSP2 favors
the hydrophobic interactions in water rich mobile phase.
Similar trends were observed in EtOH-containing and IPA-
containing mobile phases (Table 2) with exception of
analytes 1 and 2. For these analytes, k1 was larger on
CSP2 at higher EtOH or IPA (70 vol%) content.
The nature of the alcoholic modiﬁer (MeOH, EtOH, IPA)
exerted a great effect on the retention, whereas the selectivity
and resolution did not change substantially. The effect of the
EtOH or IPA content was measured in the aqueous mobile
phases containing 10, 30, 50, and 70 vol% of alcohol and
10mM of AcOH. For all analytes at constant organic modiﬁer
and acid content of H2O/alcoholic modiﬁer (90/10 and 30/
70 v/v) and 10.0mM AcOH, the retention factors of ﬁrst elut-
ing enantiomers on both columns in most cases were largest
in EtOH-containing mobile phases (exceptions were 1c,1d
and 2c,2d on CSP1 and 4c,4d on CSP2 at H2O/alcohol/acid
[30/70/10 v/v/mM]) (Table 2). It was generally observed on
both columns that k1 in H2O/alcoholic modiﬁer/AcOH (90/
10/10 v/v/mM) was smallest in IPA-containing eluent system
(exception was 2c,2d), whereas in the mobile phase with
higher alcohol content, H2O/alcoholic modiﬁer/AcOH
(30/70/10 v/v/mM) k1 was smallest in MeOH-containing mo-
bile phase (exceptions were 1c,1d and 4a,4b). In the former
case, the hydrophobic interactions between analytes and CSP
in the presence of IPA decrease to a larger extent than in the
presence of MeOH, whereas in the latter case, the more apolar
IPA promotes the HILIC interactions; the higher carbon num-
ber of the alcohols was disadvantageous for polar interactions
between the mobile phase and amino acids.
However, thenatureof the alcoholicmodiﬁerexhibiteda small
effect on the enantioselectivity and resolution; that is, the non-
chiral interactions between the CSP and the analytes are more
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favored than the chiral ones. Table 3 presents selecteddata of the
optimized separations (RS> 1) on CSP1 and CSP2 in H2O/
MeOH/AcOH,H2O/EtOH/AcOH,andH2O/IPA/AcOHmobile
phases where the ﬁnal concentration of AcOHwas 10.0mM.
Effects of the Nature and Content of the Acidic Modiﬁer in
the Mobile Phase
The effects of the nature and content of the acidic modiﬁer on
the separation were investigated by the separation of analytes
3a,3b, 3c,3d, 4a,4b, and 4c,4d in an aqueous mobile phase
at a constant concentration of the organic modiﬁer. A compari-
son of the chromatographic data obtained with HCOOH, AcOH,
TFA, HClO4, H2SO4, or H3PO4 as acidic modiﬁer at a constant
concentration of 10mM in a hydro-organic mobile phase
containing MeOH, EtOH, or IPA (70% v/v) demonstrated
that in most cases, larger k values were obtained on the
application of AcOH or HCOOH (Table 4; for analytes
3c,3d and 4c,4d, similar results were obtained).
TABLE 1. Retention factors of the ﬁrst eluting enantiomer (k1), separation factors (a), resolutions (RS), and elution sequences for
the resolution of stereoisomers of isoxazoline-fused cispentacin analogs on chiral stationary phase 1 (CSP1) and retention factors of
the ﬁrst eluting enantiomer (k1) on chiral stationary phases 2 (CSP2) in MeOH-containing mobile phase
Compound Mobile phase (v/v/mM)
CSP1 CSP2
k1 a RS Elution sequence k1
1a,1b 90/10/10 0.20 1.20 0.25 b< a 0.51
70/30/10 0.07 1.00 0.00 — 0.25
50/50/10 0.06 1.00 0.00 — 0.18
30/70/10 0.23 1.00 0.00 — 0.26
10/90/10 1.20 1.11 0.65 b< a 0.33
5/95/10 1.84 1.12 0.75 b< a 0.41
1c,1d 90/10/10 0.92 1.75 2.70 c< d 0.62
70/30/10 0.51 1.67 1.85 c< d 0.47
50/50/10 0.80 1.00 0.00 — 0.28
30/70/10 5.92 1.00 0.00 — 0.50
10/90/10 22.70 1.00 0.00 — 1.13
5/95/10 30.52 1.00 0.00 — 1.70
2a,2b 90/10/10 0.15 1.08 0.25 b< a 0.42
70/30/10 0.06 1.00 0.00 — 0.32
50/50/10 0.06 1.00 0.00 — 0.20
30/70/10 0.21 1.00 0.00 — 0.27
10/90/10 0.99 1.17 0.70 b< a 0.29
5/95/10 1.50 1.18 1.25 b< a 0.33
2c,2d 90/10/10 0.54 1.00 0.00 — 0.88
70/30/10 0.84 1.00 0.00 — 0.63
50/50/10 1.49 1.06 0.20 n.d. 0.65
30/70/10 3.72 1.07 0.20 n.d. 1.02
10/90/10 14.04 1.10 0.30 n.d. 1.05
5/95/10 18.28 1.10 0.45 c< d 1.48
3a,3b 90/10/10 0.07 1.20 0.30 n.d. 0.53
70/30/10 0.19 1.00 0.00 — 0.18
50/50/10 0.25 1.21 0.45 a< b 0.20
30/70/10 0.61 1.23 0.85 a< b 0.27
10/90/10 2.48 1.23 1.10 a< b 0.33
5/95/10 3.58 1.24 1.20 a< b 0.42
3c,3d 90/10/10 0.08 1.00 0.00 — 0.56
70/30/10 0.12 1.00 0.00 — 0.27
50/50/10 0.13 1.61 0.55 d< c 0.18
30/70/10 0.33 1.56 0.85 d< c 0.27
10/90/10 1.37 1.38 0.75 d< c 0.38
5/95/10 1.84 1.37 0.60 d< c 0.50
4a,4b 90/10/10 0.16 1.00 0.00 — 0.65
70/30/10 0.18 1.00 0.00 — 0.42
50/50/10 0.23 1.30 0.60 a< b 0.30
30/70/10 0.56 1.30 0.85 a< b 0.26
10/90/10 2.40 1.26 1.65 a< b 0.24
5/95/10 3.20 1.25 1.60 a< b 0.24
4c,4d 90/10/10 0.08 1.00 0.00 — 0.66
70/30/10 0.09 1.65 0.35 n.d. 0.35
50/50/10 0.15 2.03 0.65 d< c 0.18
30/70/10 0.28 1.60 0.85 d< c 0.24
10/90/10 1.01 1.47 1.60 d< c 0.30
5/95/10 1.31 1.46 0.80 d< c 0.32
Chromatographic conditions: mobile phase, H2O/MeOH/AcOH (v/v/mM); ﬁnal concentration of AcOH, 10.0mM; ﬂow rate, 0.5mlmin1; detection, 210 nm.
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H2SO4, HClO4, H3PO4, and TFA in the same concentration
as AcOH demonstrated much lower levels of pH. At lower pH,
the ionic strength of the mobile phase is higher. The HILIC
interaction of a protonated ionic analyte with the polar mobile
phase is then expected to increase, with a consequent
decrease in the retention time. The ionic strength can act as
a “shield” with respect to the host–guest complex formation,
a higher ionic strength reducing the retention. Larger a and
especially RS values were obtained in most cases when
AcOH, HCOOH, and in some cases when H2SO4 (especially
with EtOH or IPA in the mobile phase) were applied.
The increase of the AcOH or H2SO4 content of the aqueous
mobile phase decreased the retention factors (Table 5). As
the acid content was elevated, the ionic strength of the mobile
phase increased, whereas pH decreased, resulting in a
decrease in the retention time. a and RS exhibited different
behavior for analytes containing amino and carboxyl groups
in cis (a,b) or trans (c,d) positions. a for both types of analytes
increased with increasing acid content, whereas RS increased
for analytes a,b and decreased for analytes c,d with increas-
ing acid concentration.
Effects of the Structures of the Analytes
The structures of the analytes inﬂuenced the chiral recog-
nition. In the reversed-phase mode, methyl or ethyl substitu-
tion exerted a slight effect on the retention. On CSP1 at a given
mobile phase composition, the methyl-substituted analogs in
most cases interacted more strongly with the selector than did
the ethyl-substituted ones, resulting in larger retentions.
On CSP2, the interactions depended on the composition
of the mobile phase (Table 1). At higher water content, the
ethyl-substituted analogs exhibited stronger interactions with
CSP2, whereas at higher MeOH content, the methyl-substituted
TABLE 3. Selected data of retention factors of the ﬁrst eluting enantiomer (k1), separation factors (a), resolutions (RS), and elution
sequences for the resolution of stereoisomers of isoxazoline-fused cispentacin analogs on chiral stationary phase 1 (CSP1) and chiral
stationary phase 2 (CSP2) in MeOH-containing, EtOH-containing, and IPA-containing mobile phases
Compound Column Mobile phase (v/v/mM) k1 a RS Elution sequence
1c,1d CSP1 90/10/10,b 1.51 1.50 1.50 d< c
CSP2 50/50/10,a 0.28 1.52 1.20 d< c
CSP2 30/70/10,c 4.92 1.29 1.10 d< c
2a,2b CSP1 30/70/10,b 0.70 3.21 1.80 a< b
2c,2d CSP1 90/10/10,b 1.62 1.38 1.30 c< d
CSP1 90/10/10,c 0,65 1.43 1.40 c< d
CSP1 30/70/10,c 6.85 1.51 2.10 c< d
CSP2 90/10/10,a 0.88 1.30 1.55 c< d
3a,3b CSP2 90/10/10,a 0.53 1.71 1.50 b< a
CSP2 30/70/10,c 0.46 1.49 1.15 a< b
3c,3d CSP1 30/70/10,b 1.22 1.32 1.25 c< d
CSP2 30/70/10,c 0.58 1.89 1.80 d< c
4a,4b CSP2 30/70/10,c 0.45 1.43 1.00 a< b
4c,4d CSP1 30/70/10,b 1.17 1.31 1.30 d< c
CSP1 30/70/10,c 0.75 1.26 1.00 d< c
CSP2 30/70/10,c 0.52 1.87 1.80 c< d
Chromatographic conditions: mobile phase, a, H2O/MeOH/AcOH (v/v/mM); b, H2O/EtOH/AcOH (v/v/mM); c, H2O/IPA/AcOH (v/v/mM); ﬁnal concentration
of AcOH, 10.0mM; ﬂow rate, 0.5mlmin1; detection, 210 nm.
TABLE 4. Chromatographic data, retention factors (k1), separation factors (a), and resolutions (RS) for analytes 3a,3b and 4a,4b on
chiral stationary phase 1 at mobile phase composition of H2O/MeOH/acid, H2O/EtOH/acid and H2O/IPA/acid (30/70/10 v/v/
mM) with variation of the type of acidic modiﬁer
Compound Nature of acid
Mobile phase: H2O/alcohol/acid (30/70/10 (v/v/mM)
H2O/MeOH H2O/EtOH H2O/IPA
k1 a RS k1 a RS k1 a RS
3a,3b HCOOH 0.69 1.26 0.85 1.03 1.20 0.55 1.53 1.17 0.45
AcOH 0.61 1.23 0.85 1.84 1.18 0.40 0.93 1.10 0.25
TFA 0.39 1.15 0.10 0.24 1.15 0.25 0.43 1.10 0.10
HClO4 0.31 1.13 0.10 0.53 1.10 0.10 0.71 1.13 0.10
H2SO4 0.36 1.24 0.20 0.50 1.35 0.75 0.96 1.21 1.10
H3PO4 0.54 1.16 0.65 0.59 1.18 0.65 0.72 1.10 0.45
4a,4b HCOOH 0.65 1.33 1.00 1.09 1.20 0.65 1.35 1.21 0.80
AcOH 0.56 1.30 0.85 1.78 1.20 0.60 0.79 1.15 0.60
TFA 0.41 1.18 0.20 0.25 1.31 0.10 0.23 1.35 0.30
HClO4 0.32 1.17 0.10 0.52 1.17 0.10 0.75 1.06 0.10
H2SO4 0.36 1.19 0.20 0.50 1.45 1.40 0.40 1.51 1.10
H3PO4 0.57 1.16 0.50 0.57 1.14 0.65 0.64 1.19 0.60
Chromatographic conditions: ﬂow rate, 0.5ml min1; detection, 205 nm.
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ones did so. However, the stronger interactions resulted in
larger a and RS values in only a few cases, indicating almost
the same interactions of the two enantiomers with the CSP.
Through the steric interactions, the position of the methyl or
ethyl group inﬂuenced the a and RS values. 3a,3b were better
separated than 1a,1b on both CSP1 and CSP2, whereas 1c,1d
TABLE 5. Chromatographic data, retention factors (k0), separation factors (a), and resolutions (RS) for analytes 4a,4b and 4c,4d on
chiral stationary phase 1 at mobile phase compositions of H2O/alcohol/acid (30/70/0.5-30 v/v/mM) with variation of the type
(AcOH or H2SO4) and concentration of the acidic modiﬁers
Compound
Concentration
of acid (mM)
Mobile phase
H2O/MeOH/AcOH (30/70/0.5–30 v/v/mM) H2O/IPA/H2SO4 (30/70/0.5–30 v/v/mM)
k1 a RS k1 a RS
4a,4b 0.5 1.64 1.10 0.20 1.06 1.21 0.75
1.0 1.56 1.11 0.25 0.66 1.29 0.85
5.0 1.11 1.20 0.65 0.51 1.44 0.90
10.0 0.61 1.23 0.85 0.40 1.51 1.10
20.0 0.58 1.25 0.90 0.37 1.55 1.15
30.0 0.43 1.28 0.95 0.31 1.61 1.25
4c,4d 0.5 0.46 1.35 1.00 0.39 1.57 1.10
1.0 0.39 1.51 0.95 0.26 1.71 1.00
5.0 0.37 1.53 0.80 0.09 2.53 0.95
10.0 0.20 1.87 0.75 0.05 3.59 0.90
20.0 0.08 2.85 0.65 0.05 3.55 0.85
30.0 0.02 4.00 0.20 0.07 3.97 0.75
Chromatographic conditions: ﬂow rate, 0.5mlmin1; detection, 205 nm.
Fig. 3. Separation of the four stereoisomers of isoxazoline-fused cispentacin derivatives. Chromatographic conditions: column, for all analytes CSP1; mobile
phase, for analyte 1 (1A), H2O/MeOH/AcOH (5/95/30 v/v/mM), for (1B), H2O/MeOH/AcOH (90/10/10 v/v/mM), for analyte 2, H2O/EtOH/AcOH (50/50/
10 v/v/mM), and for analytes 3 and 4, H2O/MeOH/AcOH (5/95/10 v/v/mM); temperature, 25 C for analyte 1 (1B) and 5 C for analytes 1 (1A), 2, 3, and 4;
ﬂow rate, 0.5mlmin1; detection, 210 nm.
HPLC ENANTIOSEPARATION OF UNUSUAL AMINO ACIDS 823
Chirality DOI 10.1002/chir
exhibited better separation efﬁciency than 3c,3d. 4a–4d in
general underwent better enantioseparation than 2a–2d.
Elution sequences were determined in all cases, but no
consistent elution sequencewas observed. The primary interac-
tion in the course of chiral recognition is the complex formation
between the protonated amino group of the analyte and CSP,
but neither the conﬁguration of the carbon atom attached to
the amino group nor that of the carbon atom attached to the
carboxyl group determined the elution sequence.
Separation of the Four Enantiomers of Isoxazoline-fused
2-Aminocyclopentanecarboxylic Acids
Because the biological activities of isoxazoline-fused 2-amino-
cyclopentanecarboxylic acid analogs depend strongly on their
conﬁgurations, it is essential to separate and identify not only
the enantiomers but also the diastereomers in one chromato-
graphic run. The data listed in Tables 1 and 2 reveal that sepa-
ration of the four stereoisomers was achieved in only a few
cases. In attempts to attain separation of the four stereoisomers
in one chromatographic run, the separation was optimized by
variation of the CSPs, the mobile phase composition, and
temperature. Figure 3 illustrates data relating to the optimal
enantioseparation of the four stereoisomers of the isoxazoline-
fused 2-aminocyclopentanecarboxylic acid analogs. Analytes
1a,1b and 1c,1d could be separated on CSP1 in two different
eluent systems.
CONCLUSIONS
The enantiomeric separations of isoxazoline-fused 2-amino-
cyclopentanecarboxylic acid analogs were investigated on
(+)-(18-crown-6)-2,3,11,12-tetracarboxylic acid-based CSPs.
The chromatographic retention behavior and resolution
proved to depend on the natures and concentrations of the
alcoholic and acidic modiﬁers, the temperature, and the
nature and positions of the substituents. The elution sequence
was determined in all cases, but no general rule could be found
to describe the elution behavior of these compounds.
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